400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / TGF-beta/Smad / Bcr-Abl & Src & c-Kit / 达沙替尼
CAS No.: 302962-49-8
Synonyms: BMS-354825;达沙替尼
Dasatinib is a potent and dual Abl/ Src inhibitor IC50 of < 1 nM/0.8 nM respectively and also inhibits c-Kit (WT)/c-Kit (D816V) with IC50 of 79 nM/37 nM.
生物活性
靶点 | Abl IC50:1nM | c-Kit IC50:79nM | c-Kit (D816V) IC50:37nM | Src IC50:0.8nM |
动物研究 | |||||||||||||||||||||||||||||||||||||||||
剂量 | Mice[5]: 1.5 mg/kg (i.v.), 1.25 mg/kg - 5 mg/kg (p.o.) | ||||||||||||||||||||||||||||||||||||||||
给药途径 | i.v., p.o. | ||||||||||||||||||||||||||||||||||||||||
动物药代数据 |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02546791 | - | - | Completed | - | - |
NCT00339144 | Tumors | Phase 1 | Completed | - | Japan ... more >> Local Institution Osakasayama City, Osaka, Japan, 589-0014 Local Institution Koto-Ku, Tokyo, Japan, 135-0063 Collapse << |
NCT01876953 | Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse << | Phase 1 Phase 2 | Completed | - | United States, California ... more >> City of Hope Medical Center Duarte, California, United States, 91010 Collapse << |
实验方案
技术信息
CAS号 | 302962-49-8 | 储存条件 |
|
|||||||||||
分子式 | C22H26ClN7O2S | 运输 | 蓝冰 | |||||||||||
分子量 | 488.01 | 别名 | BMS-354825;达沙替尼 | |||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
697 | - | Growth Inhibition Assay | - | IC50=0.19987 μM | SANGER |
8-MG-BA | - | Growth Inhibition Assay | - | IC50=0.15458 μM | SANGER |
A101D | - | Growth Inhibition Assay | - | IC50=1.03043 μM | SANGER |
A253 | - | Growth Inhibition Assay | - | IC50=3.73246 μM | SANGER |
A388 | - | Growth Inhibition Assay | - | IC50=0.05095 μM | SANGER |
A3-KAW | - | Growth Inhibition Assay | - | IC50=0.98452 μM | SANGER |
A498 | - | Growth Inhibition Assay | - | IC50=0.07284 μM | SANGER |
A4-Fuk | - | Growth Inhibition Assay | - | IC50=38.1009 μM | SANGER |
A549 | - | Growth Inhibition Assay | 72 h | IC50=8.2 μM | 23567960 |
A704 | - | Growth Inhibition Assay | - | IC50=0.01491 μM | SANGER |
ALL3 | 0.1μM | Cytotoxic Assay | 72 h | IC50=0.0004 μM | 19889540 |
ALL-PO | - | Growth Inhibition Assay | - | IC50=10.7938 μM | SANGER |
ARH-77 | - | Growth Inhibition Assay | - | IC50=3.46915 μM | SANGER |
BA/F3 | - | Growth Inhibition Assay | 72 h | IC50=6.589 μM | 23088644 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl M351T mutant with IC50 of 0.00083μM | 23088644 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces antiproliferative activity against mouse BA/F3 cells expressing wild type Bcr-Abl with IC50 of 0.0045μM | 23088644 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces antiproliferative activity against mouse BA/F3 cells expressing Bcr-Abl T315I mutant with IC50 of 1.714μM | 23088644 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells expressing BCR-ABL F486S mutant assessed as growth Inhibition with IC50 of 0.0009μM | 23301703 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells expressing BCR-ABL E255K mutant assessed as growth Inhibition with IC50 of 0.0032μM | 23301703 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells expressing BCR-ABL G250E mutant assessed as growth Inhibition with IC50 of 0.0051μM | 23301703 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells expressing BCR-ABL Q252H mutant assessed as growth Inhibition with IC50 of 0.008μM | 23301703 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells expressing BCR-ABL E359V mutant assessed as growth Inhibition with IC50 of 0.0013μM | 23301703 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells expressing wild type BCR-ABL assessed as growth Inhibition with IC50 of 0.0019μM | 23301703 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells expressing BCR-ABL Y253H mutant assessed as growth Inhibition with IC50 of 0.0023μM | 23301703 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells expressing BCR-ABL T315I mutant assessed as growth Inhibition with IC50 of 3.6μM | 23301703 |
BA/F3 | - | Growth Inhibition Assay | 72 h | Induces cytotoxicity against mouse BA/F3 cells assessed as growth Inhibition with IC50 of 2.5μM | 23301703 |
BB30-HNC | - | Growth Inhibition Assay | - | IC50=0.05437 μM | SANGER |
BB49-HNC | - | Growth Inhibition Assay | - | IC50=0.38599 μM | SANGER |
BB65-RCC | - | Growth Inhibition Assay | - | IC50=0.08227 μM | SANGER |
BC-1 | - | Growth Inhibition Assay | - | IC50=28.651 μM | SANGER |
BC-3 | - | Growth Inhibition Assay | - | IC50=12.1138 μM | SANGER |
Becker | - | Growth Inhibition Assay | - | IC50=0.03003 μM | SANGER |
BL-41 | - | Growth Inhibition Assay | - | IC50=0.29123 μM | SANGER |
BL-70 | - | Growth Inhibition Assay | - | IC50=0.000000822 μM | SANGER |
BOKU | - | Growth Inhibition Assay | - | IC50=0.49133 μM | SANGER |
BV-173 | - | Growth Inhibition Assay | - | IC50=0.000000109 μM | SANGER |
C2BBe1 | - | Growth Inhibition Assay | - | IC50=0.08308 μM | SANGER |
C6/36 | 2.5 μM | Antiviral Assay | 4 days | Inhibits viral spread in Dengue virus-infected asian tiger mosquito C6/36 cells assessed as accumulation of viral envelope protein within perinuclear region at 2.5 uM | 17360676 |
Calu-6 | - | Growth Inhibition Assay | - | IC50=3.05741 μM | SANGER |
CAN | - | Growth Inhibition Assay | - | IC50=1.82252 μM | SANGER |
CAS-1 | - | Growth Inhibition Assay | - | IC50=1.40992 μM | SANGER |
CGTH-W-1 | - | Growth Inhibition Assay | - | IC50=0.03548 μM | SANGER |
CML | - | Growth Inhibition Assay | 20 min | IC50=0.001 μM | 19219016 |
COLO-684 | - | Growth Inhibition Assay | - | IC50=46.2258 μM | SANGER |
COLO-829 | - | Growth Inhibition Assay | - | IC50=0.12213 μM | SANGER |
COR-L279 | - | Growth Inhibition Assay | - | IC50=40.2851 μM | SANGER |
CP66-MEL | - | Growth Inhibition Assay | - | IC50=0.19531 μM | SANGER |
CP67-MEL | - | Growth Inhibition Assay | - | IC50=0.20488 μM | SANGER |
CTV-1 | - | Growth Inhibition Assay | - | IC50=0.0000404 μM | SANGER |
CXF 1103L | - | Cytotoxic Assay | 4 days | IC50=4.36 μM | 23253074 |
D-247MG | - | Growth Inhibition Assay | - | IC50=6.12519 μM | SANGER |
D-263MG | - | Growth Inhibition Assay | - | IC50=0.36224 μM | SANGER |
D-336MG | - | Growth Inhibition Assay | - | IC50=0.0063 μM | SANGER |
D-502MG | - | Growth Inhibition Assay | - | IC50=1.23376 μM | SANGER |
DEL | - | Growth Inhibition Assay | - | IC50=41.9086 μM | SANGER |
DJM-1 | - | Growth Inhibition Assay | - | IC50=6.48558 μM | SANGER |
DLD1 | - | Growth Inhibition Assay | 72 h | IC50=4.6 μM | 23567960 |
DMS-153 | - | Growth Inhibition Assay | - | IC50=14.0028 μM | SANGER |
DOHH-2 | - | Growth Inhibition Assay | - | IC50=0.01719 μM | SANGER |
DSH1 | - | Growth Inhibition Assay | - | IC50=0.24001 μM | SANGER |
DU145 | - | Cytotoxic Assay | 72 h | GI50=0.16 μM | 24015327 |
DU145 | 0.1 μM | Function Assay | 5 h | Inhibits human DU145 cell adhesion at 100 nM | 19462975 |
DU145 | 0.1 μM | Kinase Assay | 5 h | Inhibits cSrc in human DU145 cells assessed as reduction of phosphorylated Src Y416 level at 100 nM | 19462975 |
DU145 | 0.1 μM | Kinase Assay | 5 h | Inhibits cSrc in human DU145 cells assessed as reduction of phosphorylated FAK Y576/Y577 level at 100 nM | 19462975 |
DU-4475 | - | Growth Inhibition Assay | - | IC50=8.21652 μM | SANGER |
EB-3 | - | Growth Inhibition Assay | - | IC50=34.3117 μM | SANGER |
EHEB | - | Growth Inhibition Assay | - | IC50=10.0656 μM | SANGER |
EM-2 | - | Growth Inhibition Assay | - | IC50=0.00000108 μM | SANGER |
EoL-1-cell | - | Growth Inhibition Assay | - | IC50=0.0000131 μM | SANGER |
ES4 | - | Growth Inhibition Assay | - | IC50=1.05145 μM | SANGER |
ES6 | - | Growth Inhibition Assay | - | IC50=0.03193 μM | SANGER |
ES8 | - | Growth Inhibition Assay | - | IC50=32.1252 μM | SANGER |
ETK-1 | - | Growth Inhibition Assay | - | IC50=0.02832 μM | SANGER |
EVSA-T | - | Growth Inhibition Assay | - | IC50=9.27793 μM | SANGER |
EW-16 | - | Growth Inhibition Assay | - | IC50=0.76178 μM | SANGER |
EW-24 | - | Growth Inhibition Assay | - | IC50=0.78165 μM | SANGER |
GAK | - | Growth Inhibition Assay | - | IC50=31.2686 μM | SANGER |
GB-1 | - | Growth Inhibition Assay | - | IC50=0.02157 μM | SANGER |
GCIY | - | Growth Inhibition Assay | - | IC50=0.09656 μM | SANGER |
GI-1 | - | Growth Inhibition Assay | - | IC50=1.3622 μM | SANGER |
GI-ME-N | - | Growth Inhibition Assay | - | IC50=0.06118 μM | SANGER |
GT3TKB | - | Growth Inhibition Assay | - | IC50=9.35546 μM | SANGER |
GXF251L | - | Cytotoxic Assay | 4 days | IC50=2.25 μM | 23253074 |
HAL-01 | - | Growth Inhibition Assay | - | IC50=19.7543 μM | SANGER |
HC-1 | - | Growth Inhibition Assay | - | IC50=24.5551 μM | SANGER |
HCC1187 | - | Growth Inhibition Assay | - | IC50=35.8052 μM | SANGER |
HCC1599 | - | Growth Inhibition Assay | - | IC50=32.3325 μM | SANGER |
HCC2157 | - | Growth Inhibition Assay | - | IC50=37.9946 μM | SANGER |
HCE-4 | - | Growth Inhibition Assay | - | IC50=0.26439 μM | SANGER |
HCE-T | - | Growth Inhibition Assay | - | IC50=1.56714 μM | SANGER |
HCT116 | - | Growth Inhibition Assay | 72 h | IC50=2.3 μM | 23521020 |
HEK293 | 10 μM | Function Assay | - | Induces binding affinity to human full-length His-tagged Myt1 kinase expressed in HEK293 cells with IC50 of 0.063μM | 22770610 |
HEL | - | Growth Inhibition Assay | - | IC50=10.4776 μM | SANGER |
HMEC | - | Cytotoxic Assay | 72 h | GI50=1.8 μM | 24015327 |
HOP-62 | - | Growth Inhibition Assay | - | IC50=0.01834 μM | SANGER |
Hs578T | - | Cytotoxic Assay | 72 h | GI50=0.03 μM | 24015327 |
HT-144 | - | Growth Inhibition Assay | - | IC50=0.53609 μM | SANGER |
Huh7 | 2.5 μM | Antiviral Assay | 4 days | Inhibits viral spread in Dengue virus-infected human Huh7 cells assessed as accumulation of viral envelope protein within perinuclear region at 2.5 uM | 17360676 |
HUTU-80 | - | Growth Inhibition Assay | - | IC50=0.3142 μM | SANGER |
HUVEC | 0.15 μM | Growth Inhibition Assay | 72 h | Induces antiangiogenic activity in HUVEC co-cultured with vascular smooth muscle cells assessed as Inhibition of cell growth at 0.15 uM | 22853993 |
HUVEC | 15 μM | Function Assay | 72 h | Induces antiangiogenic activity in HUVEC co-cultured with vascular smooth muscle cells assessed as Inhibition of network formation at 1.8 to 15 uM | 22853993 |
IA-LM | - | Growth Inhibition Assay | - | IC50=12.4445 μM | SANGER |
IST-MEL1 | - | Growth Inhibition Assay | - | IC50=0.1345 μM | SANGER |
IST-MES1 | - | Growth Inhibition Assay | - | IC50=0.08552 μM | SANGER |
IST-SL2 | - | Growth Inhibition Assay | - | IC50=0.50302 μM | SANGER |
JiyoyeP-2003 | - | Growth Inhibition Assay | - | IC50=1.73466 μM | SANGER |
J-RT3-T3-5 | - | Growth Inhibition Assay | - | IC50=8.96529 μM | SANGER |
JVM-2 | - | Growth Inhibition Assay | - | IC50=2.36284 μM | SANGER |
JVM-3 | - | Growth Inhibition Assay | - | IC50=37.2338 μM | SANGER |
K5 | - | Growth Inhibition Assay | - | IC50=0.16489 μM | SANGER |
K562 | - | Growth Inhibition Assay | 72 h | IC50=0.001 μM | 17956080 |
K-562 | - | Growth Inhibition Assay | - | IC50=0.000000266 μM | SANGER |
KALS-1 | - | Growth Inhibition Assay | - | IC50=0.0949 μM | SANGER |
KARPAS-422 | - | Growth Inhibition Assay | - | IC50=0.33997 μM | SANGER |
KARPAS-45 | - | Growth Inhibition Assay | - | IC50=7.51671 μM | SANGER |
KG-1 | - | Growth Inhibition Assay | - | IC50=4.60845 μM | SANGER |
KGN | - | Growth Inhibition Assay | - | IC50=0.01942 μM | SANGER |
KINGS-1 | - | Growth Inhibition Assay | - | IC50=0.16666 μM | SANGER |
KLE | - | Growth Inhibition Assay | - | IC50=0.11317 μM | SANGER |
KM12 | - | Cytotoxic Assay | 72 h | GI50=7.44 μM | 24015327 |
KNS-42 | - | Growth Inhibition Assay | - | IC50=1.24412 μM | SANGER |
KNS-81-FD | - | Growth Inhibition Assay | - | IC50=23.146 μM | SANGER |
KP-N-YS | - | Growth Inhibition Assay | - | IC50=12.9283 μM | SANGER |
KS-1 | - | Growth Inhibition Assay | - | IC50=0.0273 μM | SANGER |
KU812 | - | Growth Inhibition Assay | - | IC50=0.11883 μM | SANGER |
KURAMOCHI | - | Growth Inhibition Assay | - | IC50=0.03487 μM | SANGER |
L-540 | - | Growth Inhibition Assay | - | IC50=15.0672 μM | SANGER |
LAMA-84 | - | Growth Inhibition Assay | - | IC50=0.00000321 μM | SANGER |
LB1047-RCC | - | Growth Inhibition Assay | - | IC50=0.00989 μM | SANGER |
LB2241-RCC | - | Growth Inhibition Assay | - | IC50=9.02012 μM | SANGER |
LB2518-MEL | - | Growth Inhibition Assay | - | IC50=0.14162 μM | SANGER |
LB373-MEL-D | - | Growth Inhibition Assay | - | IC50=0.82508 μM | SANGER |
LB771-HNC | - | Growth Inhibition Assay | - | IC50=2.57551 μM | SANGER |
LB831-BLC | - | Growth Inhibition Assay | - | IC50=0.04609 μM | SANGER |
LB996-RCC | - | Growth Inhibition Assay | - | IC50=0.00991 μM | SANGER |
LC-1F | - | Growth Inhibition Assay | - | IC50=27.3245 μM | SANGER |
LC-2-ad | - | Growth Inhibition Assay | - | IC50=0.02586 μM | SANGER |
LOXIMVI | - | Growth Inhibition Assay | - | IC50=0.31503 μM | SANGER |
LP-1 | - | Growth Inhibition Assay | - | IC50=7.54782 μM | SANGER |
LS-123 | - | Growth Inhibition Assay | - | IC50=0.14064 μM | SANGER |
LS-411N | - | Growth Inhibition Assay | - | IC50=48.4748 μM | SANGER |
LXF-289 | - | Growth Inhibition Assay | - | IC50=0.03956 μM | SANGER |
LXFA 983L | - | Cytotoxic Assay | 4 days | IC50=0.0565 μM | 23253074 |
M07e | - | Growth Inhibition Assay | 72 h | IC50=0.0012 μM | 17956080 |
M07ep210 | - | Growth Inhibition Assay | 72 h | IC50=0.00007 μM | 17956080 |
MALME-3M | - | Cytotoxic Assay | 72 h | GI50=6.61 μM | 24015327 |
MC116 | - | Growth Inhibition Assay | - | IC50=0.1141 μM | SANGER |
MCF7 | - | Growth Inhibition Assay | 72 h | IC50=2.57 μM | 23521020 |
MDA-MB-231 | - | Growth Inhibition Assay | 72 h | IC50=0.012 μM | 15615512 |
MEG-01 | - | Growth Inhibition Assay | - | IC50=0.0000098 μM | SANGER |
MFH-ino | - | Growth Inhibition Assay | - | IC50=0.04724 μM | SANGER |
MHH-NB-11 | - | Growth Inhibition Assay | - | IC50=43.0818 μM | SANGER |
MHH-PREB-1 | - | Growth Inhibition Assay | - | IC50=0.74469 μM | SANGER |
MLMA | - | Growth Inhibition Assay | - | IC50=0.14032 μM | SANGER |
MMAC-SF | - | Growth Inhibition Assay | - | IC50=8.79307 μM | SANGER |
MN-60 | - | Growth Inhibition Assay | - | IC50=15.1979 μM | SANGER |
MOLT-16 | - | Growth Inhibition Assay | - | IC50=29.6292 μM | SANGER |
MOLT-4 | - | Growth Inhibition Assay | - | IC50=26.6753 μM | SANGER |
MONO-MAC-6 | - | Growth Inhibition Assay | - | IC50=8.27066 μM | SANGER |
MPP-89 | - | Growth Inhibition Assay | - | IC50=0.04049 μM | SANGER |
murine mast cell | 1 μM | Function Assay | 24 h | Inhibits antigen-induced IL6 secretion in IgE primed mouse mast cells at 1 uM | 17684099 |
MV-4-11 | - | Growth Inhibition Assay | - | IC50=4.36454 μM | SANGER |
MZ1-PC | - | Growth Inhibition Assay | - | IC50=0.03119 μM | SANGER |
MZ2-MEL | - | Growth Inhibition Assay | - | IC50=0.28537 μM | SANGER |
MZ7-mel | - | Growth Inhibition Assay | - | IC50=0.47911 μM | SANGER |
NALM-6 | - | Growth Inhibition Assay | - | IC50=0.19295 μM | SANGER |
NB13 | - | Growth Inhibition Assay | - | IC50=19.4877 μM | SANGER |
NB17 | - | Growth Inhibition Assay | - | IC50=3.63847 μM | SANGER |
NB5 | - | Growth Inhibition Assay | - | IC50=1.39827 μM | SANGER |
NB6 | - | Growth Inhibition Assay | - | IC50=9.92259 μM | SANGER |
NB69 | - | Growth Inhibition Assay | - | IC50=0.14436 μM | SANGER |
NCCIT | - | Growth Inhibition Assay | - | IC50=2.86616 μM | SANGER |
NCI60 | - | Cytotoxic Assay | 72 h | GI50=5.7 μM | 24015327 |
NCI-H1304 | - | Growth Inhibition Assay | - | IC50=28.1628 μM | SANGER |
NCI-H1355 | - | Growth Inhibition Assay | - | IC50=0.11028 μM | SANGER |
NCI-H1395 | - | Growth Inhibition Assay | - | IC50=42.0163 μM | SANGER |
NCI-H1648 | - | Growth Inhibition Assay | - | IC50=0.02011 μM | SANGER |
NCI-H1838 | - | Growth Inhibition Assay | - | IC50=1.30733 μM | SANGER |
NCI-H2107 | - | Growth Inhibition Assay | - | IC50=43.4846 μM | SANGER |
NCI-H2126 | - | Growth Inhibition Assay | - | IC50=2.87552 μM | SANGER |
NCI-H2141 | - | Growth Inhibition Assay | - | IC50=24.7754 μM | SANGER |
NCI-H23 | - | Growth Inhibition Assay | 72 h | IC50=2.27 μM | 23521020 |
NCI-H446 | - | Growth Inhibition Assay | - | IC50=0.6276 μM | SANGER |
NCI-H460 | - | Growth Inhibition Assay | 72 h | IC50=8.99 μM | 23521020 |
NCI-H510A | - | Growth Inhibition Assay | - | IC50=19.3973 μM | SANGER |
NCI-H64 | - | Growth Inhibition Assay | - | IC50=29.6253 μM | SANGER |
NCI-H661 | - | Growth Inhibition Assay | 72 h | IC50=7.8 μM | 23567960 |
NCI-H720 | - | Growth Inhibition Assay | - | IC50=20.2733 μM | SANGER |
NCI-H747 | - | Growth Inhibition Assay | - | IC50=0.08362 μM | SANGER |
NCI-SNU-16 | - | Growth Inhibition Assay | - | IC50=8.56128 μM | SANGER |
NEC8 | - | Growth Inhibition Assay | - | IC50=44.336 μM | SANGER |
NKM-1 | - | Growth Inhibition Assay | - | IC50=1.30859 μM | SANGER |
NMC-G1 | - | Growth Inhibition Assay | - | IC50=0.11606 μM | SANGER |
no-10 | - | Growth Inhibition Assay | - | IC50=0.31931 μM | SANGER |
no-11 | - | Growth Inhibition Assay | - | IC50=0.50228 μM | SANGER |
NOS-1 | - | Growth Inhibition Assay | - | IC50=0.00613 μM | SANGER |
NTERA-S-cl-D1 | - | Growth Inhibition Assay | - | IC50=0.12283 μM | SANGER |
OCI-AML2 | - | Growth Inhibition Assay | - | IC50=5.86154 μM | SANGER |
OCUB-M | - | Growth Inhibition Assay | - | IC50=1.04412 μM | SANGER |
OMC-1 | - | Growth Inhibition Assay | - | IC50=27.1422 μM | SANGER |
ONS-76 | - | Growth Inhibition Assay | - | IC50=0.42951 μM | SANGER |
OPM-2 | - | Growth Inhibition Assay | - | IC50=4.27685 μM | SANGER |
OS-RC-2 | - | Growth Inhibition Assay | - | IC50=0.0203 μM | SANGER |
OVCAR-4 | - | Growth Inhibition Assay | - | IC50=0.37433 μM | SANGER |
PAXF 1657L | - | Cytotoxic Assay | 4 days | IC50=0.121 μM | 23253074 |
PC3 | - | Growth Inhibition Assay | 72 h | IC50=0.0094 μM | 15615512 |
PC3 | 0.1 μM | Function Assay | 5 h | Inhibits human PC3 cell adhesion at 100 nM | 19462975 |
PC3 | 0.1 μM | Kinase Assay | 5 h | Inhibits cSrc in human PC3 cells assessed as reduction of phosphorylated Src Y416 level at 100 nM | 19462975 |
PC3 | 0.1 μM | Kinase Assay | 5 h | Inhibits cSrc in human PC3 cells assessed as reduction of phosphorylated FAK Y576/Y577 level at 100 nM | 19462975 |
PF-382 | - | Growth Inhibition Assay | - | IC50=0.17678 μM | SANGER |
Plasmodium falciparum | 10 μM | Function Assay | 15 min | Inhibits Plasmodium falciparum proliferation by inhibiting the Function of PfCDPK1 protein with IC50 of 1.17μM | 24550330 |
PRXF DU145 | - | Cytotoxic Assay | 4 days | IC50=0.0623 μM | 23253074 |
PSN1 | - | Growth Inhibition Assay | - | IC50=0.04474 μM | SANGER |
QIMR-WIL | - | Growth Inhibition Assay | - | IC50=0.70629 μM | SANGER |
Raji | - | Growth Inhibition Assay | - | IC50=13.7497 μM | SANGER |
RCC10RGB | - | Growth Inhibition Assay | - | IC50=0.4911 μM | SANGER |
REH | - | Growth Inhibition Assay | - | IC50=20.6357 μM | SANGER |
RKO | - | Growth Inhibition Assay | - | IC50=0.52966 μM | SANGER |
RL95-2 | - | Growth Inhibition Assay | - | IC50=0.1038 μM | SANGER |
RPMI-6666 | - | Growth Inhibition Assay | - | IC50=7.27067 μM | SANGER |
RPMI-8866 | - | Growth Inhibition Assay | - | IC50=17.4454 μM | SANGER |
RS4-11 | - | Growth Inhibition Assay | - | IC50=7.65787 μM | SANGER |
RXF 393NL | - | Cytotoxic Assay | 4 days | IC50=0.0217 μM | 23253074 |
RXF393 | - | Growth Inhibition Assay | - | IC50=0.02357 μM | SANGER |
SBC-1 | - | Growth Inhibition Assay | - | IC50=1.57984 μM | SANGER |
SF126 | - | Growth Inhibition Assay | - | IC50=0.3541 μM | SANGER |
SF268 | - | Growth Inhibition Assay | - | IC50=0.17404 μM | SANGER |
SF539 | - | Growth Inhibition Assay | - | IC50=13.8557 μM | SANGER |
SH-4 | - | Growth Inhibition Assay | - | IC50=0.18413 μM | SANGER |
SIG-M5 | - | Growth Inhibition Assay | - | IC50=9.02493 μM | SANGER |
SJSA-1 | - | Growth Inhibition Assay | - | IC50=8.72805 μM | SANGER |
SK-LMS-1 | - | Growth Inhibition Assay | - | IC50=3.11886 μM | SANGER |
SKM-1 | - | Growth Inhibition Assay | - | IC50=9.01734 μM | SANGER |
SK-NEP-1 | - | Growth Inhibition Assay | - | IC50=8.89155 μM | SANGER |
SK-PN-DW | - | Growth Inhibition Assay | - | IC50=36.1943 μM | SANGER |
SK-UT-1 | - | Growth Inhibition Assay | - | IC50=2.16693 μM | SANGER |
SNB75 | - | Growth Inhibition Assay | - | IC50=0.04435 μM | SANGER |
SNU-C2B | - | Growth Inhibition Assay | - | IC50=1.30589 μM | SANGER |
SR | - | Growth Inhibition Assay | - | IC50=4.49954 μM | SANGER |
SW620 | - | Cytotoxic Assay | 72 h | GI50=8.43 μM | 24015327 |
SW684 | - | Growth Inhibition Assay | - | IC50=0.3498 μM | SANGER |
SW872 | - | Growth Inhibition Assay | - | IC50=0.04161 μM | SANGER |
SW954 | - | Growth Inhibition Assay | - | IC50=0.02927 μM | SANGER |
SW962 | - | Growth Inhibition Assay | - | IC50=0.11292 μM | SANGER |
SW982 | - | Growth Inhibition Assay | - | IC50=0.01115 μM | SANGER |
T cell | - | Growth Inhibition Assay | 72 h | Inhibits anti CD3- and anti CD28-induced T cell proliferation with IC50 of 0.003μM | 17154512 |
TE-1 | - | Growth Inhibition Assay | - | IC50=0.1054 μM | SANGER |
TE-10 | - | Growth Inhibition Assay | - | IC50=0.06357 μM | SANGER |
TE-11 | - | Growth Inhibition Assay | - | IC50=0.07858 μM | SANGER |
TE-12 | - | Growth Inhibition Assay | - | IC50=0.01861 μM | SANGER |
TE-15 | - | Growth Inhibition Assay | - | IC50=0.00589 μM | SANGER |
TE-5 | - | Growth Inhibition Assay | - | IC50=1.79139 μM | SANGER |
TE-6 | - | Growth Inhibition Assay | - | IC50=1.21226 μM | SANGER |
TE-8 | - | Growth Inhibition Assay | - | IC50=0.01576 μM | SANGER |
TE-9 | - | Growth Inhibition Assay | - | IC50=0.87532 μM | SANGER |
TGBC1TKB | - | Growth Inhibition Assay | - | IC50=0.06164 μM | SANGER |
TGBC24TKB | - | Growth Inhibition Assay | - | IC50=0.04761 μM | SANGER |
TGW | - | Growth Inhibition Assay | - | IC50=11.2828 μM | SANGER |
TK10 | - | Growth Inhibition Assay | - | IC50=0.01174 μM | SANGER |
U251 | - | Cytotoxic Assay | 72 h | GI50=2.81 μM | 24015327 |
U-87-MG | - | Growth Inhibition Assay | - | IC50=30.766 μM | SANGER |
U937 | - | Growth Inhibition Assay | 72 h | IC50=12.2 μM | 23567960 |
U937 | 1 μM | Function Assay | 1 h | Reduces basal TNFalpha release in human U937 cells | 17684099 |
U937 | 1 μM | Function Assay | 1 h | Reduces LPS-induced TNFalpha release in human U937 cells | 17684099 |
UACC-257 | - | Growth Inhibition Assay | - | IC50=12.9198 μM | SANGER |
VA-ES-BJ | - | Growth Inhibition Assay | - | IC50=0.03902 μM | SANGER |
WiDr | - | Growth Inhibition Assay | 72 h | IC50=0.052 μM | 15615512 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02546791 | - | - | Completed | - | - |
NCT00339144 | Tumors | Phase 1 | Completed | - | Japan ... more >> Local Institution Osakasayama City, Osaka, Japan, 589-0014 Local Institution Koto-Ku, Tokyo, Japan, 135-0063 Collapse << |
NCT01876953 | Adult Acute Myeloid Leukemia W... more >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Collapse << | Phase 1 Phase 2 | Completed | - | United States, California ... more >> City of Hope Medical Center Duarte, California, United States, 91010 Collapse << |
NCT00940524 | Leukemia Acut... more >>e Lymphoblastic Leukemia Collapse << | Phase 1 | Completed | - | United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
NCT01488318 | Squamous Cell Carcinoma Of The... more >> Head And Neck Collapse << | Phase 2 | Terminated(PI leaving the inst... more >>itution) Collapse << | - | United States, Pennsylvania ... more >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
NCT01644773 | Diffuse Intrinsic Pontine Glio... more >>ma High-grade Glioma Collapse << | Phase 1 | Active, not recruiting | November 2020 | United States, Tennessee ... more >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Collapse << |
NCT01488318 | - | - | Terminated(PI leaving the inst... more >>itution) Collapse << | - | - |
NCT00371345 | Breast Cancer ... more >> Metastasis Collapse << | Phase 2 | Completed | - | United States, California ... more >> Ucsf-Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Florida Mayo Clinic Florida Jacksonville, Florida, United States, 32224 United States, Massachusetts Dana-Farber Cancer Inst Boston, Massachusetts, United States, 02115 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 United States, North Carolina University Of North Carolina At Chapel Hill Chapel Hill, North Carolina, United States, 275997305 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas University Of Texas Md Anderson Cancer Ctr Houston, Texas, United States, 77030 Argentina Local Institution Haedo, Buenos Aires, Argentina, 1684 Local Institution Buenos Aires, Argentina, 1019 Local Institution Buenos Aires, Argentina, 1185 Belgium Local Institution Bruxelles, Belgium, 1000 Local Institution Bruxelles, Belgium, 1200 France Local Institution Dijon Cedex, France, 21079 Local Institution Paris, France, 75231 Local Institution Saint Herblain Cedex, France, 44805 Local Institution Toulouse Cedex 3, France, 31052 Italy Local Institution Modena, Italy, 41100 Peru Local Institution Arequipa, Peru Local Institution Lima, Peru, 34 Local Institution Lima, Peru, LIMA 11 Spain Local Institution Barcelona, Spain, 08035 Local Institution Lleida, Spain, 25198 Local Institution Madrid, Spain, 28041 Collapse << |
NCT00538980 | - | - | Terminated(This study was term... more >>inated due to lack of efficacy.) Collapse << | - | - |
NCT02709083 | Chronic Myelogenous Leukemia ... more >> Chronic Myeloid Leukemia Leukemia Collapse << | Phase 2 | Terminated(Original principal ... more >>investigator left institution) Collapse << | - | United States, Georgia ... more >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Collapse << |
NCT00371345 | - | - | Completed | - | - |
NCT02709083 | - | - | Terminated(Original principal ... more >>investigator left institution) Collapse << | - | - |
NCT02815059 | Acute Lymphoblastic Leukemia | Phase 1 | Withdrawn(Termination of Inves... more >>tigator Initiated Studies using Ibrutinib) Collapse << | - | United States, Utah ... more >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Collapse << |
NCT02113319 | Acute Myelogenous Leukemia | Phase 2 | Completed | - | France ... more >> University Hospital Angers, France, 49 933 Collapse << |
NCT01725204 | Leukemia, Myeloid, Chronic-Pha... more >>se Collapse << | Phase 2 | Completed | - | Finland ... more >> Helsinki University Central Hospital Helsinki, Finland Norway Bergen University Central Hospital Bergen, Norway Rikshospitalet Oslo, Norway Stavanger University Hospital Stavanger, Norway University Hospital of Northern Norway Tromsø, Norway St Olavs Hospital - Trondheim University Hospital Trondheim, Norway Sweden Linköping University Hospital Linköping, Sweden Sunderby Sjukhus Luleå, Sweden Lund University Hospital Lund, Sweden Karolinska University Hospital Stockholm, Sweden Sundsvall County Hospital Sundsvall, Sweden Umeå University Hospital Umeå, Sweden Uppsala University Hospital Uppsala, Sweden Örebro University Hospital Örebro, Sweden Collapse << |
NCT00339144 | - | - | Completed | - | - |
NCT00538980 | Polycythemia Vera | Phase 2 | Terminated(This study was term... more >>inated due to lack of efficacy.) Collapse << | - | United States, Georgia ... more >> Emory Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, New York Hematology/Oncology Associates of Rockland New City, New York, United States, 10956 Weill Cornell Medical College - New York Presbyterian Hospital New York, New York, United States, 10021 United States, Tennessee The Jones Clinic Germantown, Tennessee, United States, 38138 Collapse << |
NCT00162214 | Tumors | Phase 1 | Terminated | - | United States, California ... more >> Lee S. Rosen M.D. Santa Monica, California, United States, 90404 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00470054 | Extensive Stage Small Cell Lun... more >>g Cancer Limited Stage Small Cell Lung Cancer Recurrent Small Cell Lung Cancer Collapse << | Phase 2 | Completed | - | United States, Illinois ... more >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Collapse << |
NCT00254423 | Chronic Myelogenous Leukemia | Phase 2 | Active, not recruiting | November 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00470054 | - | - | Completed | - | - |
NCT00439270 | Metastatic Prostate Cancer | Phase 1 Phase 2 | Completed | - | United States, Illinois ... more >> University of Chicago Chicago, Illinois, United States, 60637 Springfield Clinic Springfield, Illinois, United States, 62703 United States, New York Hematology-Oncology Associates Of Rockland Nyack, New York, United States, 10960 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas The University Of Texas Md Anderson Cancer Center Houston, Texas, United States, 77030-4009 Collapse << |
NCT00852566 | Chronic Myeloid Leukemia | Phase 2 | Completed | - | Finland ... more >> Helsinki University Central Hospital Helsinki, Finland, 00029 Norway Bergen University Central Hospital Bergen, Norway Rikshospitalet Oslo, Norway, 0027 St. Olavs Hospital Trondheim, Norway, 7006 Sweden Lund University Hospital Lund, Sweden, 22185 Karolinska University Hospital Stockholm, Sweden, 17176 Uppsala University Hospital Uppsala, Sweden, 75185 Collapse << |
NCT00459108 | Adult Primary Hepatocellular C... more >>arcinoma Advanced Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Collapse << | Phase 2 | Terminated(Halted early for fu... more >>tility.) Collapse << | - | United States, California ... more >> University of Southern California, Norris Los Angeles, California, United States, 90033 Collapse << |
NCT01306942 | Metastatic Breast Cancer | Phase 1 Phase 2 | Active, not recruiting | June 2018 | Spain ... more >> Instituto Catalán de Oncología de Barcelona (Hospital Duran i Reynalds) Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Alvaro Cunqueiro Vigo, Pontevedra, Spain, 36204 Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital Clinic i Provincial Barcelona, Spain, 08036 Hospital General Universitario Gregorio Marañón Madrid, Spain, 28007 Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Instituto Valenciano de Oncología Valencia, Spain, 46009 Collapse << |
NCT00459108 | - | - | Terminated(Halted early for fu... more >>tility.) Collapse << | - | - |
NCT01092728 | - | - | Terminated(Slow accrual.) | - | - |
NCT01395017 | Pancreatic Cancer | Phase 2 | Completed | - | - |
NCT00364286 | - | - | Completed | - | - |
NCT01395017 | - | - | Completed | - | - |
NCT01826838 | Prostate Cancer | Phase 1 | Withdrawn(Lack of patients) | - | - |
NCT02744768 | Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | June 2021 | Italy ... more >> U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Not yet recruiting Ascoli Piceno, Italy Contact: Piero Galieni Principal Investigator: Piero Galieni Az.Ospedaliera S.G.Moscati Not yet recruiting Avellino, Italy Contact: Nicola Cantore Principal Investigator: Nicola Cantore UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Not yet recruiting Bari, Italy Contact: Giorgina Specchia Principal Investigator: Giorgina Specchia Azienda Ospedaliera - Papa Giovanni XXIII Recruiting Bergamo, Italy Contact: Alessandro Rambaldi Principal Investigator: Alessandro Rambaldi Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Not yet recruiting Bologna, Italy Contact: Giovanni Martinelli Principal Investigator: Giovanni Martinelli Divisione di Ematologia Ospedale A. Perrino Not yet recruiting Brindisi, Italy Contact: Angela Melpignano Principal Investigator: Angela Melpignano Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Recruiting Catania, Italy Contact: Francesco Di Raimondo Principal Investigator: Francesco Di Raimondo Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano Not yet recruiting Firenze, Italy Contact: Alberto Bosi Unità Operative Complesse di Ematologia 1 e 2 Centro Trapianti di Midollo dell'IRCCS AOU San Martino-IST Not yet recruiting Genova, Italy Contact: Angelo Michele Carella Principal Investigator: Angelo Michele Carella ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Not yet recruiting Lecce, Italy Contact: Nicola Di Renzo Principal Investigator: Nicola Di Renzo U.O. di Ematologia- Ospedale dell'Angelo - Mestre Recruiting Mestre, Italy Contact: Renato Bassan Principal Investigator: Renato Bassan Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano Recruiting Milano, Italy Contact: Agostino Cortelezzi Principal Investigator: Agostino Cortelezzi Ospedale Niguarda " Ca Granda" - SC Ematologia Blocco SUD, Ponti Est, Scala E, 4° piano Not yet recruiting Milano, Italy Contact: Valentina Mancini Principal Investigator: Valentina Mancini Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Recruiting Napoli, Italy Contact: Felicetto Ferrara Principal Investigator: Delicetto Ferrara Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Recruiting Napoli, Italy Contact: Fabrizio Pane Principal Investigator: Fabrizio Pane S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Recruiting Novara, Italy Contact: Gianluca Gaidano Principal Investigator: Gianluca Gaidano Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2 Recruiting Orbassano, Italy Contact: Giovanna Rege Principal Investigator: Giovanna Rege U.O. di Oncoematologia -plesso ospedaliero "A. Tortora" di Pagani Recruiting Pagani, Italy Contact: Castello Califano Principal Investigator: Castello Califano Ospedali Riuniti "Villa Sofia-Cervello" Recruiting Palermo, Italy Contact: Francesco Fabbiano Principal Investigator: Francesco Fabbiano Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia Recruiting Perugia, Italy Contact: Brunangelo Falini Principal Investigator: Brunangelo Falini Ematologia Clinica - Azienda USL di Pescara Not yet recruiting Pescara, Italy Contact: Paolo Di Bartolomeo Principal Investigator: Paolo Di Bartolomeo Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Not yet recruiting Reggio Calabria, Italy Contact: Francesca Ronco Principal Investigator: Francesca Ronco Complesso Ospedaliero S. Giovanni Addolorata Recruiting Roma, Italy Contact: Anna Chierichini Principal Investigator: Anna Chierichini Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Recruiting Roma, Italy Contact: Simona C Sica Principal Investigator: Simona Sica Università degli Studi - Policlinico di Tor Vergata Not yet recruiting Roma, Italy Contact: Adriano Venditti Principal Investigator: Adriano Venditti UOC Medicina Trasfusionale e Cellule Staminali Azienda Ospedaliera San Camillo Forlanini Not yet recruiting Roma, Italy Contact: Stefano C Mancini Principal Investigator: Stefano Mancini Policlinico Umberto I, Hematology Department Not yet recruiting Rome, Italy Contact: Roberto Foà Principal Investigator: Roberto Foà Sub-Investigator: Sabina Chiaretti Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Recruiting Rome, Italy Contact: Roberto Foà Principal Investigator: Roberto Foà Sub-Investigator: Sabina Chiaretti Sezione di Ematologia Cancer Center Humanitas Not yet recruiting Rozzano, Italy Contact: Matteo Della Porta Principal Investigator: Matteo Della Porta Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza Not yet recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla Principal Investigator: Nicola Cascavilla Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista Not yet recruiting Torino, Italy Contact: Ernesta Audisio Principal Investigator: Ernesta Audisio Struttura Complessa a Dir. Universitaria-Ematologia e Terapie Cellulari- A.S.O. Ordine Mauriziano, P.O. Umberto I-Ospedale Torino Not yet recruiting Torino, Italy Contact: Alessandro Cignetti Principal Investigator: Alessandro Cignetti Struttura Complessa a Dir. Universitaria-Ematologia e Terapie Cellulari- A.S.O. Ordine Mauriziano, P.O. Umberto I-Ospedale Not yet recruiting Torino, Italy Contact: Alessandro Cignetti Principal Investigator: Alessandro Cignetti Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Recruiting Verona, Italy Contact: Massimiliano Bonifacio Principal Investigator: Massimiliano Bonifacio Collapse << |
NCT00364286 | Leukemia Lymp... more >>homa Collapse << | Phase 2 | Completed | - | United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00918463 | Diffuse Large B-cell Lymphoma | Phase 2 | Terminated(The study was termi... more >>nated early due to lack of accrual.) Collapse << | - | United States, New York ... more >> Weill Cornell Medical College New York, New York, United States, 10021 Collapse << |
NCT00439270 | - | - | Completed | - | - |
NCT01660971 | Metastatic Pancreatic Adenocar... more >>cinoma Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Collapse << | Phase 1 | Active, not recruiting | - | United States, Tennessee ... more >> Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 Collapse << |
NCT02680951 | Acute Myeloid Leukemia | Phase 1 | Withdrawn(Withdrawn due to lac... more >>k of participants.) Collapse << | - | - |
NCT01357655 | Leukemia | Phase 2 | Terminated(No participants enr... more >>olled in this trial could receive the SMO antagonist as a recommended phase 2 dose was not determined by a different, concurrently-run trial.) Collapse << | - | United States, New Jersey ... more >> John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 United States, Tennessee Tennessee Oncology Pllc Nashville, Tennessee, United States, 37203 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Argentina Local Institution San Miguel De Tucuman, Tucuman, Argentina, 4000 Belgium Local Institution Antwerpen, Belgium, 2060 Local Institution Brugge, Belgium, B-8000 Canada, Alberta Local Institution Edmonton, Alberta, Canada, T6G 1Z2 Finland Local Institution Helsinki, Finland, 00290 France Local Institution Nantes, Cedex, France, 44000 Local Institution Bordeaux, France, 33076 Local Institution Le Chesnay, France, 78150 Local Institution Lille, France, 59037 Local Institution Paris Cedex 10, France, 75475 Local Institution Strasbourg Cedex, France, 67091 Local Institution Toulouse Cedex 09, France, 31059 Poland Local Institution Chorzow, Poland, 41-500 Local Institution Gdansk, Poland, 80-952 Local Institution Krakow, Poland, 30-510 Local Institution Lodz, Poland, 93-513 Local Institution Wroc#aw, Poland, 50-367 Spain Local Institution Madrid, Spain, 28006 Local Institution Madrid, Spain, 28034 Local Institution Oviedo, Spain, 33006 Local Institution Pamplona, Spain, 31008 Collapse << |
NCT00817531 | Breast Cancer | Phase 2 | Terminated(terminated due to f... more >>utility after interim analysis) Collapse << | - | United States, Texas ... more >> Baylor College of Medicine, Lester and Sue Smith Breast Center Houston, Texas, United States, 77030 Collapse << |
NCT00817531 | - | - | Terminated(terminated due to f... more >>utility after interim analysis) Collapse << | - | - |
NCT01357655 | - | - | Terminated(No participants enr... more >>olled in this trial could receive the SMO antagonist as a recommended phase 2 dose was not determined by a different, concurrently-run trial.) Collapse << | - | - |
NCT00918463 | - | - | Terminated(The study was termi... more >>nated early due to lack of accrual.) Collapse << | - | - |
NCT01092728 | Melanoma | Phase 2 | Terminated(Slow accrual.) | - | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00949988 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Unknown | - | United States, California ... more >> University of California San Diego Moores Cancer Center La Jolla, California, United States, 92093 Collapse << |
NCT00568750 | Gastrointestinal Stromal Tumor | Phase 2 | Active, not recruiting | December 2018 | Finland ... more >> Biomedicum Helsinki Helsinki, Finland, FI-00290 France Institut Bergonie Bordeaux, France, 33076 Hopital Edouard Herriot - Lyon Lyon, France, 69437 Centre Paul Strauss Strasbourg, France, 67065 Institut Gustave Roussy Villejuif, France, F-94805 Germany Universitaetsklinikum Essen Essen, Germany, D-45122 Switzerland Kantonsspital Baden Baden, Switzerland, CH-5404 Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Onkozentrum - Klinik im Park Zurich, Switzerland, 8002 City Hospital Triemli Zurich, Switzerland, CH-8063 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Collapse << |
NCT01999985 | Lung Cancer N... more >>on-small Cell Lung Cancer (NSCLC) Collapse << | Phase 1 | Active, not recruiting | March 2019 | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse << |
NCT00464620 | Rhabdomyosarcoma ... more >> Malignant Peripheral Nerve Sheath Tumors Chondrosarcoma Sarcoma, Ewing's Sarcoma, Alveolar Soft Part Chordoma Epithelioid Sarcoma Giant Cell Tumor of Bone Hemangiopericytoma Gastrointestinal Stromal Tumor (GIST) Collapse << | Phase 2 | Completed | - | United States, Arkansas ... more >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 United States, California City of Hope Duarte, California, United States, 91010 Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States, 90048 Stanford University Palo Alto, California, United States, 94304 Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, District of Columbia Washington Cancer Institute Washington, District of Columbia, United States, 20010 United States, Georgia Winship Cancer Institute at Emory University Atlanta, Georgia, United States, 30308 United States, Idaho Kootenai Cancer Center Coeur d'Alene, Idaho, United States, 83814 United States, Illinois Oncology Specialists Park Ridge, Illinois, United States, 60068 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, Pennsylvania Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas MD Anderson Houston, Texas, United States, 77030 Collapse << |
NCT00464620 | - | - | Completed | - | - |
NCT00866736 | Chronic Myeloid Leukemia | Phase 2 | Completed | - | Japan ... more >> Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Bunkyo-ku, Tokyo, Japan, 113-8677 Collapse << |
NCT02689440 | Chronic Phase Chronic Myelogen... more >>ous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia Collapse << | Phase 2 | Recruiting | February 1, 2019 | United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Hagop M. Kantarjian 713-792-7026 Principal Investigator: Hagop M. Kantarjian Collapse << |
NCT01015222 | Advanced Cancer | Phase 1 | Active, not recruiting | November 2020 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00609999 | Glioblastoma ... more >>Gliosarcoma Collapse << | Phase 1 | Completed | - | United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse << |
NCT00826449 | - | - | Completed | - | - |
NCT00672295 | Ovarian Cancer ... more >> Peritoneal Cancer Fallopian Tube Cancer Collapse << | Phase 1 | Completed | - | United States, Florida ... more >> Moffitt Cancer Center Tampa, Florida, United States, 33612-9497 United States, North Carolina Duke University Health System Durham, North Carolina, United States, 27701 Collapse << |
NCT00924352 | Metastatic Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, Connecticut ... more >> Hematology Oncology PC Stamford, Connecticut, United States, 06902 United States, Georgia Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Illinois North Shore Cancer Research Skokie, Illinois, United States, 60076 United States, Iowa Hematology Oncology Associates of the Quad Cities Bettendorf, Iowa, United States, 52722 United States, Massachusetts Baystate Medical Center Springfield, Massachusetts, United States, 01107 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, New Jersey Oncology Hematology Specialists, P.A. Denville, New Jersey, United States, 07834 United States, North Carolina The Moses H. Cone Regional Cancer Center Greensboro, North Carolina, United States, 27403 United States, Ohio North Coast Cancer Care Sandusky, Ohio, United States, 44870 United States, Pennsylvania Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee University of Tennessee Cancer Institute Memphis, Tennessee, United States, 38104 The West Clinic Memphis, Tennessee, United States, 38120 Collapse << |
NCT00924352 | - | - | Completed | - | - |
NCT01460693 | Myeloid Leukemia, Chronic, Chr... more >>onic Phase Collapse << | Phase 3 | Completed | - | United Kingdom ... more >> Freeman Hospital Newcastle-upon-Tyne, United Kingdom, NE7 7DN Collapse << |
NCT00546104 | Advanced Breast Cancer | Phase 2 | Completed | - | United States, Florida ... more >> Palm Beach Cancer Center Institute West Palm Beach, Florida, United States, 33401 United States, North Carolina Presbyterian Health Care Charlotte, North Carolina, United States, 28204 Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse << |
NCT00826449 | Lung Cancer N... more >>on-Small Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Completed | - | United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01482728 | Endometrial Cancer | Early Phase 1 | Completed | - | United States, Virginia ... more >> University of Virginia Charlottesville, Virginia, United States, 22908 Collapse << |
NCT00546104 | - | - | Completed | - | - |
NCT00566618 | Breast Cancer ... more >> Bone Metastases Collapse << | Phase 1 Phase 2 | Active, not recruiting | November 2019 | United States, Illinois ... more >> University of Chicago Chicago, Illinois, United States, 60637 United States, North Carolina Duke University Durham, North Carolina, United States, 27708 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01761890 | - | - | Recruiting | November 2020 | Italy ... more >> Centro Oncologico Basilicata Not yet recruiting Rionero in Vulture, Potenza, Italy Contact: Pellegrino Musto, MD, PhD Principal Investigator: Pellegrino MUSTO, Pr. Sub-Investigator: Giuseppe Pietrantuono, Dr. S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy Contact: Massimo Pini Sub-Investigator: Gioacchino Catania Principal Investigator: Massimo Pini Azienda Ospedaliera - Nuovo Ospedale "Torrette" Recruiting Ancona, Italy Contact: Serena Rupoli Principal Investigator: Serena Rupoli Sub-Investigator: Anna Rita U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Not yet recruiting Ascoli Piceno, Italy Contact: Catia Bigazzi Principal Investigator: Catia Bigazzi Az.Ospedaliera S.G.Moscati Not yet recruiting Avellino, Italy Contact: Fausto Palmieri Principal Investigator: Fausto Palmieri Sub-Investigator: Antonio Volpe UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Not yet recruiting Bari, Italy Contact: Giorina Specchia Principal Investigator: Giorgina Specchia Sub-Investigator: Antonella Russo Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi Recruiting Bologna, Italy, 40138 Contact: Gianantonio Rosti, Dr. gianantonio.rosti@unibo.it Principal Investigator: Gianantonio Rosti, Dr. U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche Not yet recruiting Campobasso, Italy Contact: Sergio Storti Principal Investigator: Sergio Storti Sub-Investigator: Cristiana Gasbarrino, Dr. US Dipartimentale - Centro per le malattie del sangue - Ospedale Civile - S.Giacomo Not yet recruiting Castelfranco Veneto, Italy Contact: Giuseppe Tagariello, Dr. Principal Investigator: Giuseppe Tagariello, Dr. Sub-Investigator: Roberto Sartori, Dr. Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Recruiting Catania, Italy Contact: Fabio Stagno Principal Investigator: Fabio Stagno Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi Not yet recruiting Ferrara, Italy Contact: Antonio Cuneo Principal Investigator: Antonio Cuneo Sub-Investigator: Francesco Cavazzini Azienda Ospedaliera di Firenze Not yet recruiting Firenze, Italy, 50011 Contact: Alberto BOSI, Pr. Principal Investigator: Alberto BOSI, Pr. Sub-Investigator: Antonella Gozzini, Dr. Centro Aziendale di Ematologia ASL N. 6 Not yet recruiting Livorno, Italy Contact: Enrico CAPOCHIANI 0586223111 e.capochiani@nord.usl6.toscana.it Principal Investigator: Enrico Capochiani, MD Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Not yet recruiting Messina, Italy Contact: Caterina Musolino Principal Investigator: Caterina Musolino Sub-Investigator: Alessandro Allegra Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Not yet recruiting Messina, Italy Contact: Maura Brugiatelli Principal Investigator: Maura Brugiatelli Sub-Investigator: Laura Nocilli Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano Recruiting Milano, Italy Contact: Alessandra Iurlo Principal Investigator: Alessandra Iurlo Ospedale San Gennaro - ASL Napoli 1 Not yet recruiting Napoli, Italy Contact: Lucia Mastrullo Principal Investigator: Lucia Mastrullo Sub-Investigator: Maria Rosaria zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Not yet recruiting Napoli, Italy Contact: Fabrizio Pane Principal Investigator: Fabrizio Pane Sub-Investigator: Luigia Luciano Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2 Not yet recruiting Orbassano, Italy Contact: Giovanna Rege Principal Investigator: Giovanna Rege Sub-Investigator: Carmen Fava La Maddalena Casa di Cura di Alta Specialità Dipartimento Oncologico di III Livello Not yet recruiting Palermo, Italy Contact: Maurizio Musso Principal Investigator: Maurizio Musso Sub-Investigator: Ferdinando Porretto zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Not yet recruiting Palermo, Italy Contact: Diamante Turri Principal Investigator: Diamante Turri Cattedra di Ematologia CTMO Università degli Studi di Parma Not yet recruiting Parma, Italy Contact: Monica Crugnola Principal Investigator: Monica Crugnola Sub-Investigator: Franco Aversa U.O. Ematologia Clinica - Azienda USL di Pescara Not yet recruiting Pescara, Italy Contact: Roberto Di Lorenzo Principal Investigator: Roberto Di Lorenzo Sub-Investigator: Giuseppina Ricciuti Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Not yet recruiting Piacenza, Italy Contact: Daniele Vallisa, Dr. Principal Investigator: Daniele Vallisa, Dr. Sub-Investigator: Elena Trabacchi, Dr. Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Not yet recruiting Reggio Calabria, Italy Contact: Francesco Nobile Principal Investigator: Francesco Nobile Sub-Investigator: Bruno Martino Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Not yet recruiting Reggio Emilia, Italy Contact: Paolo Avanzini Principal Investigator: Paolo Avanzini Sub-Investigator: Isabella Capodanno Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia Not yet recruiting Roma, Italy Contact: Enrico Montefusco Principal Investigator: Enrico Montefusco Sub-Investigator: Raffaele Porrini Complesso Ospedaliero S. Giovanni Addolorata Not yet recruiting Roma, Italy Contact: Michele Cedrone, Dr. Sub-Investigator: Barbara Anaclerico, Dr. Principal Investigator: Michele Cedrone, Dr. Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo Not yet recruiting Roma, Italy Contact: Leonardo Pacilli Principal Investigator: Leonardo Pacilli S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Not yet recruiting Roma, Italy Contact: Atelda Romano, Dr. Principal Investigator: Atelda Romano, Dr. Sub-Investigator: Laura Nocilli, Dr. U.O.C. Ematologia - Ospedale S.Eugenio Not yet recruiting Roma, Italy Contact: Elisabetta Abruzzese Principal Investigator: Elisabetta Abruzzese Sub-Investigator: Monika Trawinska Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Not yet recruiting Roma, Italy Contact: Simona Sica Principal Investigator: Simona Sica Sub-Investigator: Federica Sorà Rotondo Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza Not yet recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla Principal Investigator: Nicola Cascavilla Sub-Investigator: Antonietta Pia U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte" Not yet recruiting Siena, Italy Contact: Monica Bocchia Principal Investigator: Monica Bocchia Sub-Investigator: Lara Aprile Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista Not yet recruiting Torino, Italy Contact: Patrizia Pregno Principal Investigator: Patrizia Pregno Sub-Investigator: Paola Riccomagno Clinica Ematologica - Policlinico Universitario Not yet recruiting Udine, Italy Contact: Mario Tiribelli Principal Investigator: Mario Tiribelli Sub-Investigator: Luciana Marin Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Not yet recruiting Verona, Italy Contact: Giovanni Pizzolo Principal Investigator: Giovanni Pizzolo Sub-Investigator: Massimiliano Bonifacio Collapse << |
NCT01218477 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, California ... more >> University Of California Medical Center San Francisco, California, United States, 94143 United States, Maryland Sidney Kimmel Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Texas Ut M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8N 3Z5 Local Institution Toronto, Ontario, Canada, M5G 2M9 Finland Local Institution Helsinki, Finland, 00290 France Local Institution Bordeaux, France, 33076 Local Institution Poitiers Cedex, France, 86021 Germany Local Institution Frankfurt/main, Germany, 60590 Italy Local Institution Bologna, Italy, 40138 Local Institution Orbassano(To), Italy, 10043 United Kingdom Local Institution Glasgow, United Kingdom, G12 0YN Collapse << |
NCT00608361 | Adult Acute Lymphoblastic Leuk... more >>emia in Remission Adult B Acute Lymphoblastic Leukemia Adult Hepatocellular Carcinoma Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult Solid Neoplasm Adult T Acute Lymphoblastic Leukemia Advanced Adult Hepatocellular Carcinoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-Cell Lymphoma Chronic Lymphocytic Leukemia Cutaneous B-Cell Non-Hodgkin Lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Hepatosplenic T-Cell Lymphoma Intraocular Lymphoma Localized Non-Resectable Adult Liver Carcinoma Localized Resectable Adult Liver Carcinoma Lymphomatous Involvement of Non-Cutaneous Extranodal Site Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Nodal Marginal Zone Lymphoma Progressive Hairy Cell Leukemia Initial Treatment Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Liver Carcinoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-Cell Leukemia/Lymphoma Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Small Intestinal Lymphoma Splenic Marginal Zone Lymphoma Stage II Small Lymphocytic Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-Cell Leukemia/Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IIIA Mycosis Fungoides and Sezary Syndrome Stage IIIB Mycosis Fungoides and Sezary Syndrome Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-Cell Leukemia/Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Stage IVA Mycosis Fungoides and Sezary Syndrome Stage IVB Mycosis Fungoides and Sezary Syndrome T-Cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Hairy Cell Leukemia Waldenstrom Macroglobulinemia Collapse << | Phase 1 | Completed | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Los Angeles County-USC Medical Center Los Angeles, California, United States, 90033 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Kansas Hays Medical Center Hays, Kansas, United States, 67601 Hutchinson Regional Medical Center Hutchinson, Kansas, United States, 67502 University of Kansas Cancer Center Kansas City, Kansas, United States, 66160 Olathe Cancer Center Olathe, Kansas, United States, 66061 Via Christi Hospital-Pittsburg Pittsburg, Kansas, United States, 66762 Salina Regional Health Center Salina, Kansas, United States, 67401 Saint Francis Hospital and Medical Center - Topeka Topeka, Kansas, United States, 66606 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, Missouri Truman Medical Center Kansas City, Missouri, United States, 64108 United States, Texas Audie L Murphy Veterans Affairs Hospital San Antonio, Texas, United States, 78209 Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 University Hospital San Antonio, Texas, United States, 78229 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Scott and White Memorial Hospital Temple, Texas, United States, 76508 United States, Washington Swedish Medical Center-Edmonds Edmonds, Washington, United States, 98026 Swedish Cancer Institute-Issaquah Issaquah, Washington, United States, 98029 Swedish Medical Center-Ballard Campus Seattle, Washington, United States, 98107 Swedish Medical Center-First Hill Seattle, Washington, United States, 98122-4307 University of Washington Medical Center Seattle, Washington, United States, 98195 Collapse << |
NCT03414450 | Ph+ Acute Lymphoblastic Leukem... more >>ia (Ph+ALL) Ph- Acute Lymphoblastic Leukemia (Ph-ALL) Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+) Collapse << | Phase 1 | Withdrawn(Withdrawal requested... more >> by D3) Collapse << | February 2023 | United States, Georgia ... more >> Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Maryland The Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20874 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Singapore Singapore General Hospital Singapore, Singapore, 169608 Collapse << |
NCT00429949 | Relapsed, Refractory or Platea... more >>u Phase Multiple Myeloma Collapse << | Phase 2 | Completed | - | United States, Missouri ... more >> Washington Universtiy in St. Louis St. Louis, Missouri, United States, 63110 Collapse << |
NCT02776878 | Gastrointestinal Stromal Tumor | Not Applicable | Unknown | May 2018 | China, Beijing ... more >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Li Jian 008613601310849 oncogene@163.com Principal Investigator: Shen Lin Chinese PLA General Hospital Not yet recruiting Beijing, Beijing, China Contact: Wu Xin 008613683285233 Principal Investigator: Wu Xin China, Guangdong The First Affiliated Hospital,Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China Contact: Zhang Xinhua 008613828463644 Principal Investigator: Zhang Xinhua China, Jiangsu No.81 Hospital of Chinese People's Liberation Army Not yet recruiting Nanjing, Jiangsu, China Contact: Liu Xiufeng 008613357837170 Principal Investigator: Liu Xiufeng China, Shanghai Fudan University Shanghai Cancer Center Not yet recruiting Shanghai, Shanghai, China Contact: Zhou Ye 008613661736873 Principal Investigator: Zhou Ye China, Shanxi Shanxi Cancer Hospital Not yet recruiting Taiyuan, Shanxi, China, 030013 Contact: Liang Xiaobo Principal Investigator: Liang Xiaobo China, Sichuan West China Hospital , Sichuan University Not yet recruiting Chengdu, Sichuan, China Contact: Zhang Bo 008613881952600 Principal Investigator: Zhang Bo Collapse << |
NCT01218477 | - | - | Completed | - | - |
NCT00624585 | - | - | Completed | - | - |
NCT00429949 | - | - | Completed | - | - |
NCT00570700 | Hormone-refractory Prostate Ca... more >>ncer Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Prostate Cancer Recurrent Prostate Cancer Collapse << | Phase 2 | Completed | - | United States, California ... more >> City of Hope National Medical Center Duarte, California, United States, 91010 Loma Linda University Cancer Center Loma Linda, California, United States, 92354 Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 St. Joseph Hospital Orange, California, United States, 92868 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Medical University of South Carolina, and Hollings Cancer Network Charleston, South Carolina, United States, 29425 Collapse << |
NCT00624585 | Myelodysplastic Syndromes | Not Applicable | Completed | - | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse << |
NCT00570700 | - | - | Completed | - | - |
NCT02059265 | Endometrial Clear Cell Adenoca... more >>rcinoma Estrogen Receptor Negative Ovarian Clear Cell Cystadenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Recurrent Uterine Corpus Carcinoma Collapse << | Phase 2 | Active, not recruiting | - | - |
NCT02819804 | B Acute Lymphoblastic Leukemia... more >> With t(9;22)(q34;q11.2); BCR-ABL1 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Collapse << | Phase 1 | Active, not recruiting | August 2019 | United States, Illinois ... more >> Northwestern University Chicago, Illinois, United States, 60611 Collapse << |
NCT00820170 | Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, New York ... more >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
NCT00652574 | Malignant Pleural Mesothelioma | Phase 1 | Active, not recruiting | March 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01498445 | Leukemia | Phase 1 Phase 2 | Active, not recruiting | June 2021 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT03595917 | B-cell Acute Lymphoblastic Leu... more >>kemia Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL Collapse << | Phase 1 | Recruiting | November 1, 2024 | United States, Massachusetts ... more >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Marlise R Luskin, MD Contact: Jeremy Stewart 617-582-8063 jstewart13@partners.org Principal Investigator: Marlise Luskin, MD Collapse << |
NCT01392703 | Pharmacokinetic Study in Healt... more >>hy Participants Collapse << | Phase 1 | Completed | - | United States, Texas ... more >> Healthcare Discoveries Inc. San Antonio, Texas, United States, 78209 Collapse << |
NCT00787267 | Non Small Cell Lung Cancer | Phase 2 | Terminated(Poor accrual) | - | United States, North Carolina ... more >> Durham VA Medical Center Durham, North Carolina, United States, 27705 Duke University Medical Center Durham, North Carolina, United States, 27710 Duke Raleigh Raleigh, North Carolina, United States, 27609 Collapse << |
NCT00787267 | - | - | Terminated(Poor accrual) | - | - |
NCT01392703 | - | - | Completed | - | - |
NCT00979160 | Systemic Mastocytosis | Phase 2 | Unknown | December 2012 | Italy ... more >> Istituto di ematologia "L e A Seragnoli" - Policlinico universitario Sant'Orsola-Malpighi Not yet recruiting Bologna, Italy, 40138 Contact: Giovanni Martinelli, MD +39516363680 giovanni.martinelli2@unibo.it Contact: Barbara Lama, MD +390516363827 barbara.lama@unibo.it Sub-Investigator: Stefania Paolini, MD Dipartimento di Ematologia - S.O.D. di Ematologia Università degli Studi di Firenze - Azienda Ospedaliera Careggi Not yet recruiting Firenze, Italy, 50134 Contact: Alessandro Vannucchi, MD +39 0557947688 a.vannucchi@unifi.it Sub-Investigator: Lisa Pieri, MD Divisione di Ematologia Ospedale Niguarda Ca' Grande Not yet recruiting Milano, Italy, 20162 Contact: Roberto Cairoli, MD +39 02 64442668 roberto.cairoli@ospedaleniguarda.it Divisione di Allergologia e Immunologia Clinica, Università Federico II Not yet recruiting Napoli, Italy, 80131 Contact: Massimo Triggiani, MD +390817462218 triggian@unina.it Sub-Investigator: Diomira Magliacane, MD Divisione di Ematologia Università di Torino Ospedale San Luigi Gonzaga Not yet recruiting Orbassano (TO), Italy, 10043 Contact: Daniela Cilloni, MD +39 011 9026610 daniela.cilloni@unito.it Sub-Investigator: Emanuela Messa, MD Istituto di Ematologia Università degli Studi di Pavia - Policlinico S. Matteo IRCCS Not yet recruiting Pavia, Italy, 27100 Contact: Serena Merante, MD +39 0382 503082 s.merante@smatteo.pv.it Unità di Ematologia e Trapianto Osseo CROB, Centro di Riferimento Oncologico di Basilicata +39 0972 726729 Fax +30 0972 726217 e-mail: p.musto@crob.it Not yet recruiting Rionero in Vulture (Pz), Italy Contact: Pellegrino Musto, MD +39 0972 726729 p.musto@crob.it Ematologia Tor Vergata University Hospital Not yet recruiting Roma, Italy, 00133 Contact: Adriano Venditti, MD +39 06 20903219 adriano.venditti@uniroma2.it Principal Investigator: Sergio Amadori, MD Divisione di Ematologia Policlinico Universitario "Agostino Gemelli" Roma, Italy, 00168 Ematologia e Trapianti Università degli Studi di Siena - Policlinico S. Maria alle Scotte Not yet recruiting Siena, Italy, 53100 Contact: Michela Rondoni, MD +39 0577 586798 michela.rondoni3@unibo.it Principal Investigator: Francesco Lauria, MD Divisione di Ematologia e Trapianto Midollo Osseo Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" Not yet recruiting Udine, Italy, 33100 Contact: Mario Tiribelli, MD +39 0432 55966 mario.tiribelli@uniud.it Principal Investigator: Renato Fanin, MD Sezione di Ematologia - Dipartimento di Medicina Clinica e Sperimentale Policlinico G.B.Rossi - Università degli Studi di Verona Not yet recruiting Verona, Italy, 37134 Contact: Roberta Zanotti, MD +39 045 8074812 roberta.zanotti@univr.it Collapse << |
NCT02954523 | EGFR Gene Mutation ... more >> Nonsmall Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Recruiting | November 2021 | United States, District of Col... more >>umbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Jeanette Crawford, RN 202-687-0893 crawfojg@georgetown.edu Contact: Tisdrey Torres, RN 202-687-9861 tt665@georgetown.edu Principal Investigator: Giuseppe Giaccone, MD PhD Sub-Investigator: Chul Kim, MD United States, New Jersey John Theurer Cacner Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Allison Abate 551-996-0233 alison.abate@hackensackmeridian.org Principal Investigator: Martin Gutierrez, MD Collapse << |
NCT01724879 | Philadelphia Positive Acute Ly... more >>mphoblastic Leukemia Collapse << | Phase 2 | Completed | - | Germany ... more >> Robert Bosch Krankenhaus Stuttgart, Baden-Württemberg, Germany, 70376 Klinikum der Universität Regensburg Regensburg, Bayern, Germany, 93042 University Hospital of Frankfurt, Medical Dept. II Frankfurt, Hessen, Germany, 60590 Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Universitätsklinikum Essen Essen, NRW, Germany, 45147 Universitätsklinik Münster Münster, NRW, Germany, 48149 Universitätsklinik Dresden Dresden, Sachsen, Germany, 01307 Uniklinik Aachen Aachen, Germany, 52074 Charité Universitätsmedizin Berlin Berlin, Germany, 13353 University Hospital Düsseldorf Düsseldorf, Germany, 40225 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, 20099 Universitätsklinik Köln Köln, Germany, 50937 Universität Leipzig, José-Carreras-Haus Leipzig, Germany, 04103 Universitätskliniken Mainz Mainz, Germany, 55101 Klinikum Mannheim Mannheim, Germany, 68167 Universitätsklinikum Großhadern München, Germany, 81377 Klinikum Nürnberg Nord Nürnberg, Germany, 90419 Klinikum Oldenburg Oldenburg, Germany, 26133 Universität Rostock Rostock, Germany, 18055 Medizinische Universitätsklinik Ulm Ulm, Germany, 89070 Medizinische Poliklinik der Universität Würzburg Würzburg, Germany, 97070 Collapse << |
NCT02011945 | Chronic Myeloid Leukemia | Phase 1 | Active, not recruiting | August 9, 2019 | United States, Georgia ... more >> Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Massachusetts Dana Faber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Texas Ut Southwestern Medical Center At Dallas Dallas, Texas, United States, 75390 The University Of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin Froedtert Hospital & Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Australia, New South Wales Local Institution St Leonards, New South Wales, Australia, 2065 Australia, South Australia Local Institution Adelaide, South Australia, Australia, 5000 Australia, Victoria Local Institution Parkville, Victoria, Australia, 3050 Canada, Nova Scotia QEII Health Sciences Centre-VG Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hopital Maisonneuve-Rosemont Montreal, Quebec, Canada, H1T 2M4 France Local Institution Bordeaux, France, 33000 Germany Campus Virchow Klinikum Der Charite Berlin, Germany, 13353 Universitaetsklinikum Bonn Bonn, Germany, 53127 Universitaetsklinikum Carl Gustav Carus Dresden, Germany, 01307 Universitaetsklinik Frankfurt Frankfurt am Main, Germany, 60590 Italy Local Institution Napoli, Italy, 80131 Local Institution Orbassano, Italy, 10043 Local Institution Roma, Italy, 00161 Spain Local Institution Madrid, Spain, 28047 Local Institution Valencia, Spain, 46010 Collapse << |
NCT01426334 | Accelerated Phase Chronic Myel... more >>ogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia Collapse << | Phase 1 | Terminated | - | United States, Colorado ... more >> University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver, Colorado, United States, 80217-3364 Collapse << |
NCT00564876 | - | - | Terminated(Lack of accrual, st... more >>udy closed.) Collapse << | - | - |
NCT00597038 | - | - | Completed | - | - |
NCT01441882 | Refractory Chronic Lymphocytic... more >> Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Collapse << | Phase 2 | Completed | - | United States, Oregon ... more >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Collapse << |
NCT00564876 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Terminated(Lack of accrual, st... more >>udy closed.) Collapse << | - | United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse << |
NCT01441882 | - | - | Completed | - | - |
NCT01876212 | Metastatic Melanoma | Phase 2 | Active, not recruiting | June 6, 2019 | United States, Pennsylvania ... more >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
NCT02297139 | Multiple Indications Cancer | Phase 2 | Active, not recruiting | January 1, 2022 | France ... more >> Local Institution Besancon, France, 25000 Poland Local Institution Chorzow, Poland, 41-500 Local Institution Krakow, Poland, 30-510 Local Institution Lodz, Poland, 93-510 Local Institution Warsaw, Poland, 02776 Local Institution Wroclaw, Poland, 50-367 Collapse << |
NCT02129166 | Healthy Volunteers | Phase 1 | Withdrawn(PI resigned) | - | - |
NCT03079505 | Chronic Myeloid Leukemia - Chr... more >>onic Phase Collapse << | Phase 3 | Recruiting | August 2022 | Qatar ... more >> National Center for Cancer Care & Research (NCCCR) Recruiting Doha, Qatar, 3050 Contact: Mohamed Yassin Contact: Abdulqadir Nashwan 0097466473549 anashwan@hamad.qa Collapse << |
NCT00597038 | Metastatic Melanoma | Phase 1 Phase 2 | Completed | - | United States, California ... more >> Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco San Francisco, California, United States, 94115 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Collapse << |
NCT01051115 | Chronic Lymphocytic Leukemia | Phase 2 | Unknown | January 2016 | Netherlands ... more >> Maastricht university medical center Not yet recruiting Maastricht, Limburg, Netherlands, 6229 HX Contact: Michel van Gelder, MD, PhD +31-43 - 387 6543 m.van.gelder@mumc.nl Academic Medical Center Recruiting Amsterdam, NH, Netherlands, 1105 AZ Contact: Marjolein Spiering, Ms +31-20-5669111 m.spiering@amc.nl Contact: Arnon P Kater, MD, PhD +31-20-5669111 a.p.kater@amc.nl Erasmus MC-Daniel den Hoed Cancer Center Recruiting Rotterdam, ZH, Netherlands, 3015 CE Contact: Jeanette K Doorduijn, MD, PhD +31-10 7040704 j.doorduijn@erasmusmc.nl University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: Simon MG Daenen, MD, PhD +31-50 3616161 s.m.g.j.daenen@int.umcg.nl Collapse << |
NCT00858403 | Lung Cancer | Phase 2 | Terminated(Slow Accrual) | - | United States, Florida ... more >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Collapse << |
NCT00895297 | Chronic Myeloid Leukemia | Phase 2 | Terminated(Slow recruitment. N... more >>o safety concerns during this study.) Collapse << | - | France ... more >> E Herriot Hospital Lyon, France Germany University Hospital Hamburg, Germany Uniklinik Leipzig Leipzig, Germany Stiftung Deutsche Klinik für Diagnostik Wiesbaden, Germany Switzerland University Hospital Basel, Switzerland, 4031 Hopitaux Universitaires de Geneve Geneva, Switzerland United Kingdom Hammersmith Hospital London, United Kingdom, W12 0NN Collapse << |
NCT01652976 | Pancreatic Cancer Metastatic | Phase 2 | Active, not recruiting | January 2019 | United States, Florida ... more >> UF Health Cancer Center Gainesville, Florida, United States, 32610 Collapse << |
NCT01445509 | Solid Tumors | Phase 1 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT01609816 | Non-Hodgkin's Lymphoma ... more >> Multiple Mycosis Fungoides Hodgkin's Lymphoma Multiple Myeloma Collapse << | Phase 1 Phase 2 | Recruiting | August 2018 | United States, Michigan ... more >> Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Clinical Trials Office 800-527-6266 Sub-Investigator: Lois Ayash, M.D. Sub-Investigator: Voravit Ratanatharathorn, M.D. Sub-Investigator: Charles Schiffer, M.D. Sub-Investigator: Joseph Uberti, M.D. Sub-Investigator: Divaya Bhutani, M.D. Principal Investigator: Abhinav Deol, M.D. Collapse << |
NCT02268370 | Chronic Myeloid Leukemia | Phase 2 | Active, not recruiting | October 2021 | Canada, Alberta ... more >> Tom Baker Cancer Center Calgary, Alberta, Canada University of Alberta Hospital Edmonton, Alberta, Canada Canada, British Columbia Vancouver General Hospital Vancouver, British Columbia, Canada, V5Z1M9 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada London Health Sciences Centre London, Ontario, Canada Ottawa General Hospital Ottawa, Ontario, Canada Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Centre Hôpitallier Universitaire de Quebec - Hôpital de l'Enfant-Jésus Charlesbourg, Quebec, Canada Hopital Maisonneuve-Rosemont Montreal, Quebec, Canada McGill University Health Centre Montreal, Quebec, Canada Collapse << |
NCT01802450 | Chronic Myeloid Leukemia | Phase 2 | Unknown | December 2016 | Spain ... more >> Hospital Txagorritxu Vitoria, Alava, Spain, 01010 Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Complejo Hospitalario de Toledo - Hospital Virgen de la Salud Toledo, Castilla La Mancha, Spain, 45004 Complejo Hospitalario Universitario de Santiago Santiago de Compostela, La Coruña, Spain, 15706 Hospital San Pedro de La Rioja Logroño, La Rioja, Spain, 26006 Hospital POVISA Vigo, Pontevedra, Spain, 36211 Institut Catalá d'Oncologia L'Hospitallet Barcelona, Spain, 08907 Hospital de León León, Spain, 24071 Hospital Universitario de la Princesa Madrid, Spain, 28006 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Virgen del Rocío Sevilla, Spain, 41013 Collapse << |
NCT00858403 | - | - | Terminated(Slow Accrual) | - | - |
NCT00882583 | - | - | Terminated(Low accrual) | - | - |
NCT01342679 | Chronic Myeloid Leukemia | Phase 2 | Completed | - | Japan ... more >> Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Bunkyo-ku, Tokyo, Japan, 113-8677 Collapse << |
NCT01916785 | Chronic Myelogenous Leukemia, ... more >>BCR/ABL Positive Collapse << | Phase 2 | Completed | - | Canada ... more >> Southern Alberta Cancer Research Institute Calgary, Canada Hôpital Charles LeMoyne Greenfield Park, Canada Queen elisabeth II Health Sciences Center Halifax, Canada CH Pierre LeGardeur Lachenaie, Canada Moncton City Hospital Moncton, Canada Hôpital Général Juif - Sir. Mortimer B. Davis Montréal, Canada Hôpital Maisonneuve-Rosemont Montréal, Canada Hôpital Royal Victoria Montréal, Canada Hôpital de l'Enfant Jésus - Centre hospitalier affilié universitaire de Québec Québec, Canada Pavillon Hôtel-Dieu de Québec - Centre hospitalier universitaire de Québec Québec, Canada France CHU Angers Angers, France Hôpital Avicenne Bobigny, France Institut Bergonie Bordeaux, France Hopital MORVAN Brest, France CH René Dubos Cergy Pontoise, France Hôpital d'Instruction de Armées Percy Clamart, France Hopital Henri MONDOR Creteil, France Hôpital Claude Huriez Lille, France CH Lyon Sud Lyon, France Institut Paoli-Calmettes Marseille, France Hôpital d'Annecy Metz Tessy, France C.H.U. Brabois Nancy, France CHU Hoptel dieu Nantes, France Hôpital l'Archet 1 Nice, France CHU Caremeau Nimes, France Hopital Saint Louis Paris, France Hôpital Necker-Enfants Malades Paris, France Hôpital St Antoine Paris, France CHU Poitiers Poitiers, France CHU Rennes - Pontchaillou Rennes, France Centre René Huguenin Saint Cloud, France Hôpital Purpan Toulouse, France CHRU Bretonneau Tours, France Central Hospital Versailles, France Collapse << |
NCT01627132 | Chronic Myeloid Leukemia | Phase 2 | Recruiting | January 2019 | Japan ... more >> Nippon Medical School Recruiting Sendagi 1-1-5, Bunkyo-ku,Tokyo, Japan, 113-8603 Contact: Koiti Inokuchi, MD,PhD +81(0)3-3822-2131 inokuchi@nms.ac.jp Contact: Hisashi Wakita, MD,PhD +81(0)476-22-2311 wakita@naritasekijuji.jp Principal Investigator: Koiti Inokuchi, MD,PhD Collapse << |
NCT02047149 | Chronic Myelogenous Leukemia | Phase 1 | Terminated(Low accrual) | - | United States, Massachusetts ... more >> University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 Collapse << |
NCT00882583 | Head and Neck Cancer | Phase 1 Phase 2 | Terminated(Low accrual) | - | United States, Maryland ... more >> Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 Collapse << |
NCT01744652 | Advanced Cancers | Phase 1 | Active, not recruiting | March 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01491633 | Squamous Cell Lung Cancer | Phase 2 | Terminated(Safety issues/conce... more >>rns per DF/HCC PI) Collapse << | - | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Collapse << |
NCT02720185 | Breast Neoplasms ... more >> Triple Negative Breast Neoplasms Collapse << | Phase 2 | Recruiting | June 2020 | United States, Wisconsin ... more >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53705 Contact: Cancer Connect 800-622-8922 cancerconnect@uwcarbone.wisc.edu Principal Investigator: Kari B Wisinski, MD Collapse << |
NCT02389972 | - | - | Completed | - | China, Hubei ... more >> Local Institution Wuhan, Hubei, China, 430022 Collapse << |
NCT02389309 | Solid Tumors | Phase 1 | Recruiting | October 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse << |
NCT01643603 | Non-Hodgkin's Lymphoma ... more >> Hodgkin's Lymphoma Myeloid Leukemia Multiple Myeloma Myelodysplastic Syndrome Lymphoid Leukemia Collapse << | Phase 1 Phase 2 | Recruiting | January 31, 2019 | United States, Michigan ... more >> Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Clinical Trials Office 800-527-6266 Sub-Investigator: Lois Ayash, M.D. Sub-Investigator: Lawrence Lum, M.D. Sub-Investigator: Voravit Ratanatharathorn, M.D. Sub-Investigator: Charles Schiffer, M.D. Sub-Investigator: Joseph Uberti, M.D. Sub-Investigator: Divaya Bhutani, M.D. Principal Investigator: Abhinav Deol, M.D. Sub-Investigator: Asif Alavi, M.D. Collapse << |
NCT01310010 | Leukemia, Lymphoblastic, Acute... more >>, Philadelphia-Positive Collapse << | Phase 2 | Unknown | September 2015 | Spain ... more >> Hospital La Fe Valencia, Spain, 46009 Collapse << |
NCT03560908 | Relapsed AML ... more >>T(8;21) C-KIT Mutation Collapse << | Phase 1 | Recruiting | December 31, 2020 | China, Tianjin ... more >> HBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Hui Wei Collapse << |
NCT01850004 | Chronic Phase Chronic Myeloid ... more >>Leukemia Collapse << | Phase 2 | Active, not recruiting | October 10, 2021 | United States, California ... more >> City of Hope National Medical Center Duarte, California, United States, 91010 David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 Ucsf-Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Illinois Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, New Jersey John Theurer Cancer Center, Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Herbert Irving Comprehensive Cancer Center-Columbia University Medical Center New York, New York, United States, 10032 United States, Texas Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas, Texas, United States, 75246 MD Anderson Cancer Center Clinic Houston, Texas, United States, 77030-4000 Canada, Ontario Local Institution Toronto, Ontario, Canada, M5G 2M9 France Local Institution Paris, France, 75010 Local Institution Pessac, France, 33604 Local Institution Pierre Benite Cedex, France, 69495 Local Institution Vandoeuvre-les-Nancy Cedex, France, 54511 Germany Local Institution Aachen, Germany, D-52074 Local Institution Berlin, Germany, 13353 Local Institution Mannheim, Germany, 68167 Local Institution Rostock, Germany, 18057 Local Institution Ulm, Germany, 89081 Italy Local Institution Catania, Italy, 95123 Local Institution Firenze, Italy, 50134 Local Institution Napoli, Italy, 80131 Local Institution Orbassano, Italy, 10043 Local Institution Roma, Italy, 00144 Local Institution Roma, Italy, 00161 Spain Local Institution Las Palmas de Gran Canaria, Spain, 35010 Local Institution Madrid, Spain, 28034 Local Institution Malaga, Spain, 29010 Local Institution Oviedo, Spain, 33011 Collapse << |
NCT02428855 | Cholangiocarcinoma | Phase 2 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Collapse << |
NCT01850004 | - | - | Active, not recruiting | - | - |
NCT03625388 | Chronic Myelogenous Leukemia | Phase 2 | Not yet recruiting | July 2021 | Jordan ... more >> King Hussein Cancer Center (KHCC) Not yet recruiting Amman, Jordan, 11941 Jordan University Hospital (JUH) Not yet recruiting Amman, Jordan, 11942 Lebanon American University of Beirut Medical Center (AUBMC) Not yet recruiting Beirut, Lebanon Saudi Arabia The King Faisal Specialist Hospital and Research Centre (KFSH&RC) Not yet recruiting Riyadh, Saudi Arabia Tunisia Aziza Othmana Hospital Not yet recruiting Tunis, Tunisia, 1006 Collapse << |
NCT01398046 | Healthy | Phase 1 | Completed | - | United States, California ... more >> Clinical Research Center, UCSF San Francisco, California, United States, 94143 Collapse << |
NCT01491633 | - | - | Terminated(Safety issues/conce... more >>rns per DF/HCC PI) Collapse << | - | - |
NCT03193281 | Chronic Myeloid Leukemia | Phase 2 | Recruiting | December 31, 2023 | New Zealand ... more >> Auckland City Hospital Recruiting Auckland, New Zealand Contact: Kate Gorton Principal Investigator: Peter Browett Middlemore Hospital Recruiting Auckland, New Zealand Contact: Kate Gorton Principal Investigator: Gordon Royle Christchurch Hospital Recruiting Christchurch, New Zealand Contact: Kate Gorton Principal Investigator: Emma-Jane McDonald Dunedin Hospital Recruiting Dunedin, New Zealand Contact: Kate Gorton Principal Investigator: Lucy Pemberton Palmerston North Hospital Recruiting Palmerston North, New Zealand Contact: Kate Gorton Principal Investigator: Bart Baker Wellington Hospital Recruiting Wellington, New Zealand Contact: Kate Gorton Principal Investigator: Victoria Campion Collapse << |
NCT01660906 | - | - | Completed | - | - |
NCT01660906 | Chronic Phase Chronic Myeloid ... more >>Leukemia Collapse << | Phase 4 | Completed | - | United States, California ... more >> Pacific Cancer Medical Center Anaheim, California, United States, 92801 United States, Connecticut Cancer Center Of Central Connecticut Southington, Connecticut, United States, 06489 United States, Maryland St. Agnes Healthcare, Inc. Baltimore, Maryland, United States, 21229 United States, Ohio Promedica Hematology & Oncology Assoicates Sylvania, Ohio, United States, 43560 United States, Texas The University Of Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 France Local Institution Creteil Cedex, France, 94010 Local Institution Lille CEDEX, France, 59037 Local Institution Pierre Benite cedex, France, 69495 Local Institution Pringy Cedex, France, 74374 Local Institution Vandoeuvre les Nancy, France, 54511 Germany Local Institution Jena, Germany, 07747 Local Institution Koln, Germany, 50937 Local Institution Lubeck, Germany, 23562 Local Institution Mannheim, Germany, 68169 Local Institution Rostock, Germany, 18055 Italy Local Institution Catania, Italy, 95124 Local Institution Firenze, Italy, 50134 Local Institution Napoli, Italy, 80131 Local Institution Roma, Italy, 00144 Local Institution Roma, Italy, 00161 Local Institution Torino, Italy, 10126 Korea, Republic of Local Institution Seoul, Korea, Republic of, 137-701 Collapse << |
NCT03216070 | Chronic Myelogenous Leukemia | Phase 4 | Recruiting | October 1, 2018 | Mexico ... more >> Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitario contra el Cancer Recruiting Monterrey, Nuevo Leon, Mexico, 64460 Contact: David Gomez-Almaguer, MD +52 81 8348-8510 dr_gomez@infosel.net.mx Contact: Paola Santana, MD +52 664 3864975 paola_santana72@hotmail.com Principal Investigator: David Gomez-Almaguer, MD Sub-Investigator: Manuel Solano, MD Collapse << |
NCT01392170 | Leukemia | Phase 2 | Terminated(Slow Accrual) | - | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01392170 | - | - | Terminated(Slow Accrual) | - | - |
NCT01690065 | Chronic Myeloid Leukemia in My... more >>eloid Blast Crisis Untreated Adult Acute Myeloid Leukemia Collapse << | Phase 2 | Recruiting | December 2019 | Korea, Republic of ... more >> Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-Wook Kim, M.D., Ph.D. dwkim@catholic.ac.kr Principal Investigator: Dong-Wook Kim, M.D., Ph.D. Ulsan University Hospital Recruiting Ulsan, Korea, Republic of, 682714 Principal Investigator: Hawk Kim, M.D., Ph.D. Sub-Investigator: Jae-Hoo Park, M.D., Ph.D. Sub-Investigator: Jae-Cheol Jo, M.D., Ph.D. Collapse << |
NCT00827138 | Chronic Myeloid Leukemia | Phase 1 | Completed | - | United States, California ... more >> City of Hope Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Kansas The University of Kansas Cancer Center Kansas City, Kansas, United States, 66160 United States, Maryland Sidney Kimmel Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Collapse << |
NCT01319981 | Leukemia | Phase 2 | Active, not recruiting | December 2020 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT02897245 | - | - | Recruiting | December 2022 | France ... more >> CH Versailles Recruiting Le Chesnay, France Contact: Rousselot Philippe phrousselot@ch-versailles.fr Collapse << |
NCT02558387 | Recurrent or Metastatic Saliva... more >>ry Gland Cancer of the Head and Neck Collapse << | Phase 2 | Unknown | January 2017 | Korea, Republic of ... more >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Collapse << |
NCT01762969 | CML | Phase 2 | Recruiting | January 2020 | Israel ... more >> Rabin Medical Center Recruiting Petah tikva, Israel, 49100 Contact: Liat vid vidallit@yahoo.com Contact: Ofer , Shpilberg Collapse << |
NCT00493181 | Leukemia Chro... more >>nic Myelogenous Leukemia Chronic Myeloid Leukemia Collapse << | Phase 2 | Completed | - | United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00493181 | - | - | Completed | - | - |
NCT02888977 | - | - | Recruiting | December 2022 | France ... more >> CH Versailles Recruiting Le Chesnay, France, 78150 Contact: Rousselot Philippe, MD CHU Nimes Recruiting Nimes, France Contact: JOURDAN Eric CH Reims Recruiting Reims, France Collapse << |
NCT03117751 | Acute Lymphoblastic Leukemia ... more >> Acute Lymphoblastic Lymphoma Collapse << | Phase 2 Phase 3 | Recruiting | March 31, 2028 | United States, Tennessee ... more >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Hiroto Inaba, MD, PhD 866-278-5833 referralinfo@stjude.org Principal Investigator: Hiroto Inaba, MD, PhD Collapse << |
NCT02767063 | Leukemia, Myeloid, Chronic-Pha... more >>se Collapse << | Phase 1 Phase 2 | Recruiting | June 2021 | France ... more >> Martine GARDEMBAS Recruiting Angers, France Contact: Martine GARDEMBAS 02.41.35.44.75 MaGardembas@chu-angers.fr Pascale CONY.MAKHOUL Recruiting Annecy, France Contact: Pascale CONY.MAKHOUL 04.50.63.64.31 pconymakhoul@ch-annecygenevois.fr Thorsten BRAUN Recruiting Bobigny, France Contact: Thorsten BRAUN 01.48.95.54.58 Thorsten.braun@avc.aphp.fr Etienne Recruiting Bordeaux, France Contact: Gabriel Etienne 05.56.33.04.76 G.Etienne@bordeaux.unicancer.fr CHU Côte de Nacre Not yet recruiting Caen, France Contact: Hyacynthe Johnson-Ansah 02.31.27.25.39 Johnsonansah-a@chu-caen.fr CHU Estaing Not yet recruiting Clermont-Ferrand, France Contact: Marc BERGER mberger@chu-clermontferrand.fr CH Henri Mondor Recruiting Créteil, France Contact: ROY Lydia Rousselot Recruiting Le Chesnay, France Contact: Philippe Rousselot 01.39.63.89.09 phrousselot@ch-versailles.fr CHU Lille Recruiting Lille, France Contact: COITEUX Valérie CHU de LIMOGES Not yet recruiting Limoges, France Contact: Amélie PENOT 05.55.05.66.42 Amelie.penot@chu-limoges.fr Franck NICOLINI Recruiting Lyon, France Contact: Franck NICOLINI 04.72.11.74.01 franck.nicolini@chu-lyon.fr Institut P Calmette Recruiting Marseille, France Contact: CHARBONNIER Aude Viviane DUBRUILLE Recruiting Nantes, France Contact: Viviane DUBRUILLE 02.40.08.32.71 Viviane.dubruille@chu-nantes.fr Hopital l'Archet Not yet recruiting Nice, France Contact: Laurence LEGROS 04.92.03.58.41 legros.l@chu-nice.fr Eric JOURDAN Recruiting Nimes, France Contact: Eric JOURDAN 04.66.68.32.31 eric.jourdan@chu-nimes.fr Hôpital La Source Recruiting Orléans, France Contact: BENBRAHIM Omar Delphine REA _St louis Recruiting Paris, France Contact: Delphine REA 01.42.49.96.49 delphine.rea@aphp.fr Simona LAPUSAN_St Antoine Recruiting Paris, France Contact: Simona LAPUSAN 01.49.28.34.42 Simona.lapusan@sat.aphp.fr Cayssials Recruiting Poitiers, France Contact: Emilie Cayssials : 05.49.44. 44.72 e.cayssials@chu-poitiers.fr CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: ESCOFFRE-BARBE Martine Hôpital René Huguenin Not yet recruiting Saint-Cloud, France Contact: Sylvie GLAISNER 01.47.11.15.30 Sylvie.glaisner@curie.net Institut Universitaire contre le Cancer Not yet recruiting Toulouse, France Contact: Françoise HUGUET 05.31.15.63.56 Huguet.françoise@iuct-oncopole.fr CHU Tours Not yet recruiting Tours, France Contact: DARTIGEAS Caroline Collapse << |
NCT02638428 | Relapsed Pediatric Solid Tumor... more >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML Collapse << | Phase 2 | Recruiting | December 2023 | Korea, Republic of ... more >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung 82-2-3410-3529 kwsped@skku.edu Principal Investigator: Ki Woong Sung Collapse << |
NCT01771458 | Reccurent/Metastatic Solid Tum... more >>or Disease Collapse << | Phase 2 | Unknown | December 2016 | France ... more >> Centre régional de lutte contre le cancer de Bourgogne Georges François Leclerc Dijon, France, 21079 Centre Leon Berard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13009 Insitut Curie Paris, France, 75248 Institut Curie Hopital Rene Huguenin Saint-cloud, France, 92210 Institut de cancérologie de l'Ouest Centre René Gauducheau Saint-herblain, France, 44000 Institut Claudius Régaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre Les Nancy, France, 54500 Collapse << |
NCT03045120 | - | - | Recruiting | July 31, 2021 | - |
NCT01244750 | - | - | Active, not recruiting | August 30, 2020 | - |
NCT01397734 | Chronic Myelogenous Leukemia | Phase 1 | Terminated(Lack of enrollment ... more >>and limited funding) Collapse << | - | United States, Massachusetts ... more >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Collapse << |
NCT01207440 | Chronic Myeloid Leukemia ... more >> Ph+ Acute Lymphoblastic Leukemia Collapse << | Phase 2 | Active, not recruiting | January 30, 2019 | - |
NCT00860535 | Blast Phase Philadelphia Chrom... more >>osomes Positive (Ph+) Chronic Myelogenous Leukemia (CML) Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL) Collapse << | Phase 1 | Terminated | - | - |
NCT00816114 | - | - | Recruiting | June 2020 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jorge Cortes, M.D. 713-794-5783 jcortes@mdanderson.org Principal Investigator: Jorge Cortes, M.D. Collapse << |
NCT03023046 | Adult Acute Lymphoblastic Leuk... more >>emia Adult Lymphoblastic Lymphoma Philadelphia Chromosome Positive Collapse << | Phase 2 | Recruiting | December 1, 2022 | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ryan D. Cassaday 206-606-1202 cassaday@seattlecca.org Principal Investigator: Ryan D. Cassaday Collapse << |
NCT02779283 | Acute Lymphoblastic Leukemia ... more >> Acute Myeloid Leukemia Collapse << | Phase 1 | Recruiting | June 1, 2019 | United States, Oregon ... more >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon 503-494-8950 spurgeos@ohsu.edu Principal Investigator: Stephen E. Spurgeon Collapse << |
NCT01606579 | Acute Myeloid Leukemia ... more >> Chronic Myeloid Leukemia Collapse << | Phase 1 Phase 2 | Completed | - | United States, Georgia ... more >> Emory University / Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Massachusetts University of Massachusetts Medical Center Worcester, Massachusetts, United States, 01655 United States, New Mexico New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States, 87106 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210-1267 United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01361438 | ALL Ph Positive | Phase 2 | Active, not recruiting | December 2018 | - |
NCT02043587 | Acute Lymphocytic Leukemia ... more >> Adult Lymphoblastic Lymphoma Collapse << | Phase 2 | Active, not recruiting | January 2020 | United States, California ... more >> UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center La Jolla, California, United States, 92093 Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 Collapse << |
NCT01169753 | Chronic Myeloid Leukemia | Not Applicable | Terminated(Slow Enrollment) | - | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT02559778 | Neuroblastoma | Phase 2 | Recruiting | September 2026 | - |
NCT02596828 | Pineoblastoma | Phase 2 | Recruiting | April 2020 | Germany ... more >> University Hospital of Regensburg Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD 0043 (0)941 944 ext 2101 kinderonkologie@ukr.de Contact: Susanne Ellinger 0043 (0)941 944 ext 2063 susanne.ellinger@ukr.de Collapse << |
NCT01169753 | - | - | Terminated(Slow Enrollment) | - | - |
NCT03205267 | Chronic Myelogenous Leukaemia | Phase 2 | Recruiting | October 2019 | Germany ... more >> University Hospital Bonn Recruiting Bonn, Germany, 53127 Contact: Dominik Wolf, Prof. Dr. +49 228 287 17233 dominik.wolf@ukb.uni-bonn.de Collapse << |
NCT00860535 | - | - | Terminated | - | - |
NCT02108951 | Philidelphia Positive Chronic ... more >>Myeloid Leukaemia Collapse << | Phase 3 | Terminated(Study was terminate... more >>d because of slow recruitment) Collapse << | - | Australia, Australian Capital ... more >>Territory Novartis Investigative Site Canberra, Australian Capital Territory, Australia, 2605 Australia, New South Wales Novartis Investigative Site Kingswood, New South Wales, Australia, 2747 Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Novartis Investigative Site Liverpool, New South Wales, Australia, 2170 Novartis Investigative Site St. Leonards, New South Wales, Australia, 2065 Australia, Queensland Novartis Investigative Site Douglas, Queensland, Australia, 4810 Novartis Investigative Site Nambour, Queensland, Australia, 4560 Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Novartis Investigative Site Fitzroy, Victoria, Australia, 3065 Novartis Investigative Site Geelong, Victoria, Australia, 3220 Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Australia, Western Australia Novartis Investigative Site Murdoch, Western Australia, Australia, 6150 Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 Collapse << |
NCT02108951 | - | - | Terminated(Study was terminate... more >>d because of slow recruitment) Collapse << | - | - |
NCT01376427 | Acute Lymphoblastic Leukemia P... more >>h Positive Collapse << | Not Applicable | Recruiting | December 2019 | Spain ... more >> Hospital Germans Trias i Pujol and all Hospital Pethema Recruiting Badalona, Barcelona, Spain Contact: Jose Mª Ribera, Dr jribera@iconcologia.net Collapse << |
NCT00549848 | Acute Lymphoblastic Leukemia | Phase 3 | Active, not recruiting | November 30, 2020 | United States, Tennessee ... more >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Collapse << |
NCT01620216 | Acute Myeloid Leukemia Arising... more >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Collapse << | Phase 2 | Recruiting | March 30, 2019 | United States, Maryland ... more >> National Heart Lung and Blood Institute Not yet recruiting Bethesda, Maryland, United States, 20824 Contact: Christopher S. Hourigan 301-803-8029 hourigan@nih.gov Principal Investigator: Christopher S. Hourigan United States, Oregon OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Marc Loriaux 503-494-9383 loriauxm@ohsu.edu Principal Investigator: Marc Loriaux United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Recruiting Dallas, Texas, United States, 75390 Contact: Robert H. Collins 214-648-4155 robert.collins@utsouthwestern.edu Principal Investigator: Robert H. Collins United States, Utah Huntsman Cancer Institute/University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Tibor J. Kovacsovics 801-585-3229 tibor.kovacsovics@hci.utah.edu Principal Investigator: Tibor J. Kovacsovics Collapse << |
NCT02269267 | Leukemia, Myeloid, Chronic | Phase 2 | Active, not recruiting | December 2021 | United States, California ... more >> Helen Diller Family Comprehensive Cancer Center University of California San Francisco, California, United States, 94143 United States, Florida Moffit Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Illinois The University of Chicago Chicago, Illinois, United States, 60637 The University of Chicago Medicine Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States, 60451 United States, Massachusetts Beth Israel Deaconess Medical Center (Satellite site of Dana Farber) Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute of Wayne State University Detroit, Michigan, United States, 48201 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Weill Medical College of Cornell University New York, New York, United States, 10021 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77054 United States, Utah University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84132-2408 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 United States, Wisconsin Froedtert Hospital & Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Collapse << |
NCT02750514 | Advanced Cancer | Phase 2 | Recruiting | April 29, 2021 | - |
NCT00792948 | Acute Lymphoblastic Leukemia ... more >> Adult Acute Lymphoblastic Leukemia in Remission Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult L1 Acute Lymphoblastic Leukemia Adult L2 Acute Lymphoblastic Leukemia Adult T Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Collapse << | Phase 2 | Active, not recruiting | September 24, 2019 | - |
NCT01990196 | Prostate Cancer | Phase 2 | Recruiting | September 30, 2019 | United States, California ... more >> University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: David Choi, MPH 310-206-7168 dechoi@mednet.ucla.edu Principal Investigator: Matthew Rettig, MD Collapse << |
NCT00495872 | Solid Tumors | Phase 1 | Completed | - | United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT02883049 | B Acute Lymphoblastic Leukemia... more >> Central Nervous System Leukemia Ph-Like Acute Lymphoblastic Leukemia Testicular Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Collapse << | Phase 3 | Recruiting | - | - |
NCT01751425 | Chronic Myelogenous Leukemia, ... more >>BCR-ABL1 Positive Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission Minimal Residual Disease Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia Collapse << | Phase 1 Phase 2 | Recruiting | July 31, 2020 | United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jorge E. Cortes 713-794-5783 Principal Investigator: Jorge E. Cortes Collapse << |
NCT01549548 | - | - | - | - | United States, Oregon ... more >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Collapse << |
NCT01188278 | - | - | Completed | - | - |
NCT01602952 | Leukemia Leuk... more >>emia, Myeloid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Philadelphia Chromosome Hematologic Diseases Collapse << | Phase 1 Phase 2 | Completed | - | India ... more >> Local institution Mumbai, Maharashtra, India, 741-234 Local institution Mumbai, Mazagaon, India, 512-364 Korea, Republic of Local institution Daegu, Buk-gu, Korea, Republic of, 511-230 Local institution Jeonju, Deokjin-gu, Korea, Republic of, 212-789 Local institution Ulsan, Dong-gu, Korea, Republic of, 411-978 Local institution Anyang-si, Dongan-gu, Korea, Republic of, 751-231 Local institution Hwasun, Hwasun-eup, Korea, Republic of, 322-511 Local institution Seoul, Jongro-ku, Korea, Republic of, 231-855 Local institution Busan, Seo-gu, Korea, Republic of, 400-321 Seoul St. Mary's hospital Seoul, Seocho-gu, Korea, Republic of Local institution Suwon, Yeongtong-gu, Korea, Republic of, 781-512 Thailand Local institution Bangkok, Phyathai, Thailand, 215-714 Collapse << |
NCT01667133 | Chronic Myeloid Leukemia (CML)... more >> Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Collapse << | Phase 1 Phase 2 | Completed | - | Japan ... more >> Aichi Cancer Center Hospital Nagoya-shi, Aichi, Japan, 464-8681 Akita University Hospital Akita-shi, Akita, Japan, 010-8543 Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital Hiroshima-shi, Hiroshima, Japan, 730-8619 Kyushu University Hospital Hukuoka-shi, Hukuoka, Japan Kinki University Hospital, Faculty of Medicine Osakasayama-shi, Osaka, Japan, 589-8511 The Cancer Institute Hospital Japanese Foundation for Cancer Research Koto, Tokyo, Japan The University of Tokyo, The Institute of Medical Science Minato-ku, Tokyo, Japan Keio University Hospital Shinjuku-ku, Tokyo, Japan Osaka City University Hospital Shinjuku-ku, Tokyo, Japan National Cancer Center Hospital Chuo-ku, Tokyo, Japan Tokyo Medical University Hospital Shinjuku-ku, Tokyo, Japan Collapse << |
NCT00903734 | Advanced Cancers | Phase 1 | Completed | - | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01073436 | - | - | Terminated(Closed prematurely ... more >>due to low accrual.) Collapse << | - | United States, Michigan ... more >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Collapse << |
NCT01844765 | Leukemia Leuk... more >>emia,Pediatric Leukemia, Myleiod Leukemia, Mylegenous, Chronic Leukemia, Mylegenous, Accelerated BCR-ABL Positive Myeloproliferative Disorder Bone Marrow Disease Hematologic Diseases Neoplastic Processes Imatinib Dasatinib Enzyme Inhibitor Protein Kinase Inhibitor Collapse << | Phase 2 | Active, not recruiting | October 7, 2020 | - |
NCT01844765 | - | - | Active, not recruiting | - | - |
NCT00036738 | Adult Acute Lymphoblastic Leuk... more >>emia in Remission Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Blastic Phase Childhood Acute Lymphoblastic Leukemia in Remission Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase of Disease Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Disease Collapse << | Phase 2 | Active, not recruiting | June 27, 2019 | United States, Colorado ... more >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Collapse << |
NCT00036738 | - | - | Active, not recruiting | - | - |
NCT02015728 | Recurrent Childhood Brain Tumo... more >>r Collapse << | Not Applicable | Unknown | December 2017 | United States, Washington ... more >> Seattle Children's Seattle, Washington, United States, 98105 Collapse << |
NCT02326311 | Leukemia, Chronic Myeloid | Phase 3 | Recruiting | January 2020 | Italy ... more >> Policlinico Universitario di Milano Recruiting Milano, Italy Contact: Alessandra Iurlo, MD Collapse << |
NCT02233049 | Diffuse Intrinsic Pontine Glio... more >>ma Collapse << | Phase 2 | Recruiting | October 2018 | France ... more >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Jacques GRILL, MD, PhD 0142116209 ext +33 jacques.grill@gustaveroussy.fr Contact: Perrine CAPOLINO 0142114211 ext +33 perrine.capolino@gustaveroussy.fr Principal Investigator: Jacques GRILL, MD, PhD Collapse << |
NCT03331211 | - | - | Recruiting | September 1, 2019 | China, Guangdong ... more >> Department of Hematology,Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Xutao Guo 008613802426709 ext 1 gxt827@126.com Collapse << |
NCT02975115 | - | - | Unknown | January 2018 | - |
NCT02222272 | - | - | Unknown | December 2015 | Denmark ... more >> Rigshospitalet Copenhagen, Denmark Finland Helsinki University Central Hospital Helsinki, Finland Germany University of Freiburg Freiburg, Germany University of Muenster Muenster, Germany Hungary St Ivan & St Laszlo Hospital Budapest, Hungary Israel Chaim Sheba Medical Centre Tel-Hashomer, Israel Poland Medical University of Silesia Katowice, Poland Russian Federation St Petersburg State Medical Pavlov University St Petersburg, Russian Federation Saudi Arabia King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia United Kingdom Hammersmith London, United Kingdom Collapse << |
NCT00792948 | - | - | Active, not recruiting | - | - |
NCT01916135 | Carcinoma Sar... more >>coma Myeloma Lymphoma Melanoma Collapse << | Phase 1 | Active, not recruiting | July 2019 | United States, New York ... more >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
NCT01254864 | Prostate Cancer | Phase 2 | Active, not recruiting | March 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT02652052 | Stem Cell Transplant | Not Applicable | Recruiting | June 2020 | United States, Minnesota ... more >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Tammie Volkman, RN 507-266-1944 RSTDOMCTU@mayo.edu Contact: Erin Wissler Gerdes 507-266-1944 wisslergerdes.erin@mayo.edu Principal Investigator: Mrinal S Patnaik, MBBS Principal Investigator: Nathan K LeBrasseur, MS, PhD Principal Investigator: Shahrukh K Hashmi, MD Principal Investigator: LaTonya Hickson, MN Collapse << |
NCT02081378 | Chronic Myelogenous Leukemia ... more >> Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Collapse << | Phase 1 | Recruiting | December 20, 2022 | United States, Massachusetts ... more >> Dana Farber Cancer Institute Hematology / Oncology Recruiting Boston, Massachusetts, United States, 02215 Contact: Shannon Milillo 617-632-6840 shannon_milillo@dfci.harvard.edu Principal Investigator: Daniel J. DeAngelo United States, Michigan University of Michigan Comprehensive Cancer Center SC Recruiting Ann Arbor, Michigan, United States, +1 48109 0944 Contact: Shelagh L. Elliott 734-232-0759 shelagh@med.umich.edu Principal Investigator: Moshe Talpaz United States, New York Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Recruiting New York, New York, United States, 10065 Contact: Michael Mauro J. Mauro, MD 212-639-3107 maurom@mskcc.org Principal Investigator: Michael J. Mauro United States, Oregon Oregon Health and Science University SC-6 Recruiting Portland, Oregon, United States, 97239 Contact: Bianca Gille 503-494-4603 gille@ohsu.edu Principal Investigator: Michael J. Heinrich United States, Texas University of Texas/MD Anderson Cancer Center UT MD Anderson Recruiting Houston, Texas, United States, 77030-4009 Contact: Jorge E Cortes, MD 713-794-5783 Jcortes@mdanderson.org Principal Investigator: Jorge E. Cortes United States, Utah Huntsman Cancer Institute SC Recruiting Salt Lake City, Utah, United States, 84112 Contact: Aaron Ernst aaron.ernst@hci.utah.edu Principal Investigator: Michael W. Deininger Australia, South Australia Novartis Investigative Site Recruiting Adelaide, South Australia, Australia, 5000 France Novartis Investigative Site Recruiting Paris Cedex 10, Cedex 10, France, 75475 Novartis Investigative Site Recruiting Bordeaux, France, 33076 Germany Novartis Investigative Site Recruiting Berlin, Germany, 13353 Novartis Investigative Site Recruiting Frankfurt, Germany, 60590 Novartis Investigative Site Recruiting Jena, Germany, 07740 Italy Novartis Investigative Site Recruiting Roma, RM, Italy, 00161 Japan Novartis Investigative Site Recruiting Kobe-shi, Hyogo, Japan, 650-0017 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Seocho-gu, Korea, Republic of, 06591 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1081 HV Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169608 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28006 Collapse << |
NCT01464047 | - | - | Completed | - | Korea, Republic of ... more >> Local Institution Seoul, Korea, Republic of, 110-756 Collapse << |
NCT01467986 | Neuroblastoma Recurrent | Phase 2 | Recruiting | December 2019 | Germany ... more >> University Hospital Regensburg, Department of Pediatric Hematology and Oncology Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD +49(0)941 944-2101 selim.corbacioglu@ukr.de Principal Investigator: Selim Corbacioglu, MD Collapse << |
NCT01077544 | Chronic Myeloid Leukemia ... more >> Acute Lymphoblastic Leukemia Collapse << | Phase 1 | Completed | - | United States, Illinois ... more >> Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie Chicago, Illinois, United States, 60611 Brazil Novartis Investigative Site Barretos, SP, Brazil, 14784-400 Novartis Investigative Site Sao Paulo, SP, Brazil Novartis Investigative Site São Paulo, SP, Brazil, 08270-070 France Novartis Investigative Site Bordeaux, Aquitaine, France, 33076 Novartis Investigative Site Lille cedex, France, 59037 Novartis Investigative Site Paris, France, 75571 Novartis Investigative Site Poitiers, France, 86021 Italy Novartis Investigative Site Monza, MB, Italy, 20900 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Roma, RM, Italy, 00161 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Rotterdam, Netherlands, 3015 GJ Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117997 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Birmingham, United Kingdom, B4 6NH Novartis Investigative Site Bristol, United Kingdom, BS2 8BJ Collapse << |
NCT00779389 | Head and Neck Cancer ... more >> Non Small Cell Lung Cancer Collapse << | Phase 1 | Completed | - | United States, Pennsylvania ... more >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
NCT02690922 | ph+ Acute Lymphoblastic Leukem... more >>ia Collapse << | Phase 4 | Unknown | May 2017 | China, Hubei ... more >> Tongji hospital Enrolling by invitation Wuhan, Hubei, China, 430000 Collapse << |
NCT01746836 | Chronic Phase Chronic Myelogen... more >>ous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Collapse << | Phase 2 | Active, not recruiting | January 31, 2019 | United States, Texas ... more >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT02421926 | - | - | Withdrawn | May 2023 | Korea, Republic of ... more >> Seoul National University Bundang Hospital Seongnam, Gyong-gi Province, Korea, Republic of Korea University Ansan Hospital Ansan, Korea, Republic of Busan National University Hospital Busan, Korea, Republic of Haeundae Paik Hospital Busan, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Gachon University Gil Hospital Incheon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Soonchyunhyang University Hospital Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Collapse << |
NCT02874989 | Idiopathic Pulmonary Fibrosis ... more >>(IPF) Collapse << | Phase 1 | Recruiting | June 2019 | United States, North Carolina ... more >> Wake Forest Baptist Health Active, not recruiting Winston-Salem, North Carolina, United States, 27157 United States, Texas University of Texas Health Science Center Recruiting San Antonio, Texas, United States, 78245 Contact: Che Kelly 210-949-3898 che@uthscsa.edu Principal Investigator: Anoop Nambiar, MD Collapse << |
NCT01805843 | - | - | Completed | - | Austria ... more >> Medical University of Graz, Division of Pulmonology Graz, Austria, 8036 Collapse << |
NCT02389920 | Leukemia, Chronic Myeloid | Phase 4 | Unknown | December 2018 | - |
NCT00112775 | Leukemia | Phase 2 | Unknown | - | United States, California ... more >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Collapse << |
NCT00734864 | Glioblastoma Multiforme ... more >> Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Glioma Collapse << | Phase 1 | Withdrawn(Study drug supplier ... more >>withdrew support for the study. Study was withdrawn from the Duke IRB.) Collapse << | June 2012 | United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse << |
NCT01077544 | - | - | Completed | - | - |
NCT00936975 | Hormone-Resistant Prostate Can... more >>cer Metastatic Malignant Neoplasm in the Bone Recurrent Prostate Carcinoma Stage IV Prostate Cancer Collapse << | Phase 2 | Completed | - | United States, Massachusetts ... more >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 Collapse << |
NCT01256398 | Acute Lymphoblastic Leukemia ... more >> Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Collapse << | Phase 2 | Active, not recruiting | - | - |
NCT03173612 | Acute Myeloid Leukemia | Not Applicable | Recruiting | December 2022 | China, Tianjin ... more >> InstituteHBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Zhu Xiaofan 86-21-23909001 xfzhu@ihcams.ac.cn Principal Investigator: Guo Ye Principal Investigator: Yang Wenyu Principal Investigator: Chen Xiaojuan Principal Investigator: Chen Yumei Principal Investigator: Ruan Min Collapse << |
NCT02848131 | Chronic Kidney Disease | Phase 2 | Recruiting | May 2021 | United States, Minnesota ... more >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Tammie Volkman, RN 507-266-1944 volkman.tammie@mayo.edu Contact: Erin Wissler Gerdes 507-266-1944 wisslergerdes.erin@mayo.edu Principal Investigator: LaTonya Hickson, MD Collapse << |
NCT00816283 | Leukemia | Phase 1 | Completed | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Collapse << |
NCT00337454 | Chronic Myelogenous Leukemia | Phase 1 Phase 2 | Completed | - | Japan ... more >> Local Institution Nagoya-Shi, Aichi, Japan, 467-8602 Local Institution Nagoya, Aichi, Japan, 464-8681 Local Institution Nagoya, Aichi, Japan, 466-8550 Local Institution Maebashi, Gunma, Japan, 371-0821 Local Institution Nishinomiya-Shi, Hyogo, Japan, 663-8501 Local Institution Kagoshima-Shi, Kagoshima, Japan, 890-0064 Local Institution Isehara-Shi, Kanagawa, Japan, 259-1193 Local Institution Sendai, Miyagi, Japan Local Institution Nagasaki City, Nagasaki, Japan Local Institution Okayama-Shi, Okayama, Japan, 700-0082 Local Institution Moriguchi, Osaka, Japan, 570-8540 Local Institution Iruma-Gun, Saitama, Japan, 350-0495 Local Institution Hamamatsu-Shi, Shizuoka, Japan, 431-3192 Local Institution Bunkyo-Ku, Tokyo, Japan, 113-8677 Local Institution Chuo-Ku, Tokyo, Japan, 104-0045 Local Institution Shinjuku-Ku, Tokyo, Japan, 160-8582 Local Institution Shinjuku-Ku, Tokyo, Japan, 162-8666 Local Institution Kanagawa, Japan Local Institution Kyoto, Japan Local Institution Tochigi, Japan, 329-0498 Local Institution Tokyo, Japan Collapse << |
NCT00936975 | - | - | Completed | - | - |
NCT00780676 | Breast Cancer | Phase 2 | Terminated(Closed early for fu... more >>tility.) Collapse << | - | United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00099606 | Neoplasms | Phase 1 | Completed | - | United States, Massachusetts ... more >> Local Institution Boston, Massachusetts, United States United States, Michigan Local Institution Detroit, Michigan, United States United Kingdom Local Institution Glasgow, Strathclyde, United Kingdom Collapse << |
NCT00123474 | Myeloid Leukemia, Chronic, Chr... more >>onic-Phase Collapse << | Phase 3 | Completed | - | - |
NCT01804985 | Chronic Myeloid Leukaemia | Phase 2 | Active, not recruiting | May 2018 | United Kingdom ... more >> University of Liveprool Liverpool, United Kingdom, L69 3GL Collapse << |
NCT00780676 | - | - | Terminated(Closed early for fu... more >>tility.) Collapse << | - | - |
NCT00064233 | Leukemia | Phase 1 | Completed | - | United States, California ... more >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Collapse << |
NCT00123474 | - | - | Completed | - | - |
NCT00390793 | Acute Lymphoblastic Leukemia ... more >> BCR-ABL1 Fusion Protein Expression Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia t(9;22) Collapse << | Phase 2 | Active, not recruiting | August 31, 2020 | United States, Texas ... more >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00391989 | Lymphoblastic Leukemia, Acute | Phase 2 | Completed | - | Italy ... more >> Ospedale Sant'Anna-17 Ronciglione, Viterbo, Italy Nuovo Ospedale "Torrette" Ancona, Italy Ospedale San Donato USL 8 Arezzo, Italy Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy Università degli Studi di Bari Bari, Italy Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Azienda Spedali Civili Brescia, Italy Osp. Reg. A. Di Summa Brindisi, Italy Servizio di Ematologia - CTMO - ASL 8 P.O. Binaghi Cagliari, Italy Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino" Genova, Italy Ospedale Niguarda " Ca Granda" Milano, Italy Sez. di medicina Interna Oncologia ed Ematologia Modena, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" - Div. TERE Napoli, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy Ematologia Università Federico II Napoli, Italy Ospedale S. Luigi Gonzaga Orbassano, Italy Dip. Oncologico "La Maddalena" Palermo, Italy Div. di Ematologia - A.O. "V. Cervello" Palermo, Italy Università degli Studi di Palermo - A.U. Policlinico Palermo, Italy Div. di Ematologia IRCCS Policlinico S. Matteo Pavia, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Istituto di Ematologia- Ospedale San Carlo Potenza, Italy Ospedale S.Maria delle Croci Ravenna, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Ospedale S. Camillo Rome, Italy Ospedale S.Eugenio Rome, Italy Università Cattolica del Sacro Cuore Rome, Italy Università degli Studi di Roma "La Sapienza" Rome, Italy Università degli Studi di Tor Vergata Rome, Italy Ospedale Casa Sollievo della sofferenza San Giovanni Rotondo, Italy Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy Policlinico Universitario Udine, Italy Policlinico G.B. Rossi Verona, Italy Collapse << |
NCT00391989 | - | - | Completed | - | - |
NCT00500006 | Chronic Myelogenous Leukemia ... more >> Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Collapse << | Phase 1 | Terminated | - | - |
NCT00382668 | - | - | Completed | - | United States, Florida ... more >> University Of Miami Miami, Florida, United States, 33136 Comprehensive Phase One Miramar, Florida, United States, 33025 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Tennessee New Orleans Center For Clinical Research Knoxville, Tennessee, United States, 37920 Collapse << |
NCT03516279 | Chronic Phase Chronic Myelogen... more >>ous Leukemia, BCR-ABL1 Positive Minimal Residual Disease Collapse << | Phase 2 | Not yet recruiting | August 31, 2031 | United States, Pennsylvania ... more >> ECOG-ACRIN Cancer Research Group Recruiting Philadelphia, Pennsylvania, United States, 19103 Contact: Amer M. Zeidan 203-737-2572 amer.zeidan@yale.edu Principal Investigator: Amer M. Zeidan Collapse << |
NCT00732186 | Leukemia, Myeloid, Chronic | Phase 1 | Withdrawn | February 2011 | United States, Texas ... more >> The University Of Texas, M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01234935 | Acinar Cell Adenocarcinoma of ... more >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Collapse << | Phase 2 | Completed | - | United States, California ... more >> Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States, 91801 TORI FULLERTON (St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center) Fullerton, California, United States, 92835 Pacific Shores Medical Group Long Beach, California, United States, 90813 UCLA medical center Los Angeles, California, United States, 90024-3417 Translational Oncology Research International (TORI) Network Los Angeles, California, United States, 90095 TORI NORTHRIDGE (North Valley Hematology/Oncology Medical Group) Northridge, California, United States, 91325 UCLA Pasadena Pasadena, California, United States TORI Inland Valley (Wilshire Oncology Medical Group, Inc. ) Pomona, California, United States, 91767 TORI REDONDO BEACH (Cancer Care Associates Medical Group, Inc.) Redondo Beach, California, United States, 90277 TORI SANTA BARBARA I (Santa Barbara Hematology Oncology Medical Group, Inc.) Santa Barbara, California, United States, 93105 TORI SANTA BARBARA II (SANSUM Clinic) Santa Barbara, California, United States, 93105 TORI SANTA MARIA (Central Coast Medical Oncology Corporation) Santa Maria, California, United States, 93454 UCLA Valencia Valencia, California, United States United States, Georgia Suburban Hematology-Oncology Associates, P.A. Lawrenceville, Georgia, United States, 30045 Northwest Georgia Oncology Centers, P.C. Marietta, Georgia, United States, 30060 United States, Maryland Chevy Chase Healthcare Management, LLC Chevy Chase, Maryland, United States, 20815 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89109 Collapse << |
NCT00454753 | - | - | - | - | Korea, Republic of ... more >> Local Institution Busan, Korea, Republic of, 602-702 Local Institution Busan, Korea, Republic of, 602-739 Local Institution Daegu, Korea, Republic of, 700-310 Local Institution Daegu, Korea, Republic of, 700-721 Local Institution Daegu, Korea, Republic of, 701-600 Local Institution Daegu, Korea, Republic of, 705-030 Local Institution Daegu, Korea, Republic of, 705-825 Local Institution Daejeon, Korea, Republic of, 301-721 Local Institution Gyeonggi-do, Korea, Republic of, 431-070 Local Institution Incheon, Korea, Republic of, 400-711 Local Institution Jellanamdo, Korea, Republic of, 519-809 Local Institution Jeollabuk-do, Korea, Republic of, 561-712 Local Institution Seoul, Korea, Republic of, 110-744 Local Institution Seoul, Korea, Republic of, 120-752 Local Institution Seoul, Korea, Republic of, 130-050 Local Institution Seoul, Korea, Republic of, 134-060 Local Institution Seoul, Korea, Republic of, 134-701 Local Institution Seoul, Korea, Republic of, 135-710 Local Institution Seoul, Korea, Republic of, 136-705 Local Institution Seoul, Korea, Republic of, 137-701 Local Institution Seoul, Korea, Republic of, 138-736 Local Institution Seoul, Korea, Republic of, 150-713 Local Institution Seoul, Korea, Republic of, 158-710 Local Institution Ulsan, Korea, Republic of, 682-061 Collapse << |
NCT00349518 | Chronic Myeloid Leukemia ... more >> Acute Lymphoblastic Leukemia Collapse << | Phase 2 Phase 3 | Withdrawn | - | Hungary ... more >> Local Institution Budapest, Hungary Italy Local Institution Bologna, Italy Local Institution Orbassano (To), Italy Local Institution Roma, Italy Netherlands Local Institution Nijmegen, Netherlands Local Institution Rotterdam, Netherlands Poland Local Institution Gdansk, Poland Local Institution Katowice, Poland Local Institution Krakow, Poland Local Instiution Lodz, Poland Local Institution Lublin, Poland Local Institution Warsaw, Poland Russian Federation Local Institution Moscow, Russian Federation Local Institution St.Petersburg, Russian Federation United Kingdom Local Institution Cambridge, Cambridgeshire, United Kingdom Local Institution Glasgow, Central, United Kingdom Local Institution London, Greater London, United Kingdom Local Institution Liverpool, Merseyside, United Kingdom Local Institution Newcastle, Tyne And Wear, United Kingdom Local Institution Birmingham, West Midlands, United Kingdom Collapse << |
NCT01116128 | Myeloma | Phase 2 | Terminated(difficulty in enrol... more >>ling patients) Collapse << | - | Italy ... more >> Mario Boccadoro Torino, Italy, 10126 Collapse << |
NCT00103701 | Leukemia, Myeloid, Chronic-pha... more >>se Leukemia, Lymphoblastic, Acute, Philadelphia-positive Collapse << | Phase 1 | Completed | - | United States, California ... more >> Local Institution Los Angeles, California, United States United States, Texas Local Institution Houston, Texas, United States Collapse << |
NCT03564470 | Leukemia Leuk... more >>emia, Acute Leukemia, Lymphoblastic Leukemia, B-cell Collapse << | Phase 2 Phase 3 | Recruiting | August 30, 2020 | China, Guangdong ... more >> Department of Hematology, Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, PhD, MD 86-20-62787349 zhs1@i.smu.edu.cn Collapse << |
NCT00788125 | Brain and Central Nervous Syst... more >>em Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Kidney Cancer Liver Cancer Lymphoma Neuroblastoma Ovarian Cancer Sarcoma Testicular Germ Cell Tumor Unspecified Childhood Solid Tumor, Protocol Specific Collapse << | Phase 1 Phase 2 | Active, not recruiting | September 2019 | United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Collapse << |
NCT01471106 | Breast Cancer | Phase 2 | Active, not recruiting | January 2019 | United States, North Carolina ... more >> Duke University Durham, North Carolina, United States, 27708 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00103844 | Chronic Myeloid Leukemia ... more >> Philadelphia-Positive Myeloid Leukemia Collapse << | Phase 2 | Completed | - | - |
NCT00103844 | - | - | Completed | - | - |
NCT03318770 | - | - | Not yet recruiting | March 2023 | Italy ... more >> Dipartimento di Biotecnologie Cellulari ed Ematologia "Sapienza" Università degli Studi di Roma Not yet recruiting Rome, Italy Contact: Roberto Foà Principal Investigator: Roberto Foà Sub-Investigator: Sabina Chiaretti Collapse << |
NCT02348957 | - | - | Active, not recruiting | April 2019 | - |
NCT00720109 | Adult B Acute Lymphoblastic Le... more >>ukemia With t(9;22)(q34;q11.2); BCR-ABL1 Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Collapse << | Phase 2 Phase 3 | Completed | - | - |
NCT02523976 | Acute,Leukemia, Lymphoid | Phase 2 | Enrolling by invitation | August 2019 | China, Tianjin ... more >> Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin, China, 300020 Collapse << |
NCT00720109 | - | - | Completed | - | - |
NCT02645149 | Melanoma | Phase 4 | Not yet recruiting | August 2021 | Australia, New South Wales ... more >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez 612 9911 7200 maria.gonzalez@melanoma.org.au Principal Investigator: John Thompson Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez +612 9911 7200 maria.gonzalez@melanoma.org.au Contact: Alex Menzies +612 9911 7200 info@melanoma.org.au Sub-Investigator: Georgina Long Principal Investigator: Alex Menzies Collapse << |
NCT00700882 | Melanoma (Skin) | Phase 2 | Active, not recruiting | May 6, 2021 | - |
NCT02551718 | Acute Leukemia of Ambiguous Li... more >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Collapse << | Not Applicable | Recruiting | - | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker Collapse << |
NCT02546375 | - | - | Completed | - | United Kingdom ... more >> Royal Liverpool Hospital Liverpool, Merseyside, United Kingdom, L7 8XP Hammersmith Hospital London, United Kingdom, W12 0HS Nottingham University Hospital Nottingham, United Kingdom, NG5 1PB Collapse << |
NCT02142036 | Metastatic Cancer | Phase 2 | Active, not recruiting | January 2022 | Norway ... more >> Akershus University Hospital Lillestrøm, Norway, 1478 The Norwegian Radium Hospital Oslo, Norway, 0379 Collapse << |
NCT01703910 | Adenocarcinoma of Colon ... more >> Adenocarcinoma of Rectum Metastatic Disease Collapse << | Phase 2 | Completed | - | Spain ... more >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Collapse << |
NCT02546375 | - | - | Completed | - | - |
NCT00688766 | Gastrointestinal Stromal Tumor... more >>s Collapse << | Phase 3 | Terminated(Based on Independen... more >>t Data Monitoring Committee (IDMC) recommendation.) Collapse << | - | - |
NCT03297606 | Lymphoma, Non-Hodgkin ... more >> Multiple Myeloma Advanced Solid Tumors Collapse << | Phase 2 | Recruiting | September 2021 | Canada, British Columbia ... more >> BCCA - Vancouver Cancer Centre Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Daniel John Renouf 604 877-6000 ext 672357 Canada, Ontario London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Stephen Welch 519 685-8640 Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: John Hilton 613 737-7700 ext 70179 University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Lillian Siu 416 946-2911 Canada, Quebec The Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Cristiano Ferrario 514 398-8307 Collapse << |
NCT01636908 | Cancer Advanc... more >>ed Solid Tumors Collapse << | Not Applicable | Active, not recruiting | - | Netherlands ... more >> VUMedical Center Amsterdam, Netherlands, 1081 HV Collapse << |
NCT03020030 | Acute Lymphoblastic Leukemia, ... more >>Pediatric Collapse << | Phase 3 | Recruiting | December 2026 | United States, Massachusetts ... more >> Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Lewis Silverman, MD 617-632-6191 lewis_silverman@dfci.harvard.edu Principal Investigator: Lewis Silverman, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis Silverman, MD 617-632-6191 lewis_silverman@dfci.harvard.edu Principal Investigator: Lewis Silverman, MD United States, New York Montefiore Medical Center Recruiting Bronx, New York, United States, 104617 Contact: Lisa Gennarini, MD lfigueir@montefiore.org Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Kara Kelly, MD Kara.Kelly@RoswellPark.org Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian Recruiting New York, New York, United States, 10032 Contact: Justine Kahn, MD jk2034@cumc.columbia.edu Principal Investigator: Justine Kahn, MD United States, Rhode Island Hasbro Children's Hospital / Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Jennifer Welch, MD jwelch@lifespan.org Canada, Quebec Hospital Sainte Justine, University of Montreal Recruiting Montreal, Quebec, Canada Contact: Jean-Marie LeClerc, MD jean-marie.leclerc@umontreal.ca Principal Investigator: Jean-Marie LeClerc, MD Centre Hospitalier U. de Quebec Recruiting Quebec City, Quebec, Canada Contact: Bruno Michon, MD bruno.michon@mail.chuq.qc.ca Principal Investigator: Bruno Michon, MD Collapse << |
NCT01862965 | Chronic Graft-versus-host Dise... more >>ase Collapse << | Phase 2 | Active, not recruiting | June 2018 | Germany ... more >> Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07743 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany, 55101 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Universitätsklinikum Ulm Ulm, Germany, 89081 Deutsche Klinik fuer Diagnostik GmbH Wiesbaden, Germany, 65191 Collapse << |
NCT01460498 | Leukemia | Phase 1 Phase 2 | Active, not recruiting | August 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT01883219 | Philadelphia Chromosome Positi... more >>ve Acute Lymphocytic Leukemia Stem Cell Transplantation Minimal Residual Disease Collapse << | Phase 2 | Unknown | November 2017 | China, Guangdong ... more >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ren Lin, MD +86-020-61641613 lansinglinren@hotmail.com Collapse << |
NCT03610971 | Chronic Phase Chronic Myeloid ... more >>Leukemia Chronic Myeloid Leukemia, Chronic Phase Collapse << | Phase 2 | Not yet recruiting | January 2022 | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting Tampa, Florida, United States, 33612 Contact: Anthony McLaughlin 813-745-5941 anthony.mclaughlin@moffitt.org Contact: Kendra Sweet, M.D. 813-745-8986 kendra.sweet@moffitt.org Principal Investigator: Kendra Sweet, M.D. Collapse << |
NCT03624530 | Philadelphia Chromosome Positi... more >>ve Acute Lymphocytic Leukemia Tyrosine Kinase Inhibitor Minimal Residual Disease Allogeneic Hematopoietic Stem Cell Transplantation Collapse << | Phase 2 Phase 3 | Recruiting | July 2022 | China, Guangdong ... more >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan +86-020-62787883 356135708@qq.com Principal Investigator: Qifa Liu Collapse << |
NCT01475110 | - | - | Recruiting | December 2018 | Italy ... more >> Centro Oncologico Basilicata Recruiting Rionero in Vulture, Potenza, Italy Contact: Pellegrino Musto, MD, PhD Principal Investigator: Pellegrino MUSTO, Pr. Ospedale Recruiting Alessandria, Italy Contact: Pini Principal Investigator: Pini S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy Contact: Massimo Pini, Dr. Principal Investigator: Massimo Pini, Dr. S.G. Moscati Hospital Recruiting Avellino, Italy Contact: Fausto Palmieri, Dr. Principal Investigator: Fausto Palmieri, Dr. Ospedale Recruiting Bari, Italy Contact: Specchia Principal Investigator: Specchia Ospedale Recruiting Bologna, Italy Contact: Cagnetti Principal Investigator: Cagnetti Azienda Spedali Civili Recruiting Brescia, Italy, 25100 Contact: Domenico RUSSO Ospedale Ferrarotto Recruiting Catania, Italy Contact: Francesco Di Raimondo, Pr. Principal Investigator: Francesco Di Raimondo, Pr. Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Recruiting Ferrara, Italy, 44100 Contact: Antonio CUNEO, Pr. Principal Investigator: Antonio CUNEO, Pr. Sub-Investigator: Gian Matteo Rigolin, Dr. Policlinico di Careggi, Università delgi studi di Firenze Recruiting Firenze, Italy Contact: Alberto BOSI Principal Investigator: Alberto BOSI, Dr. Sub-Investigator: Giacomo GIANFALDONI, Dr. Clinica Ematologica - Università degli Studi Recruiting Genova, Italy Contact: Angelo Michele CARELLA, Pr. Principal Investigator: Angelo Michele CARELLA, Pr. Università degli Studi Recruiting Genova, Italy Contact: Pierri Università di Genova Recruiting Genova, Italy Contact: Pierri Principal Investigator: Pierri ASL Le1 P.O. Vito Fazzi - U.O. di Ematologia Recruiting Lecce, Italy, 73100 Contact: Nicola DI RENZO Principal Investigator: Nicola DI RENZO, Dr. A.O. Universitaria Policlinico Martina di Messina Recruiting Messina, Italy Contact: Caterina MUSSOLINO, Pr. Principal Investigator: Caterina MUSSOLINO, Pr. U.O. Ematologia e Trapianto di Midollo - Ist. Scientifico Ospedale San Raffaele Recruiting Milano, Italy, 20132 Contact: Fabio CICERI ciceri.fabio@hsr.it Principal Investigator: Fabio Ciceri, MD Federico II Recruiting Napoli, Italy Contact: Pane Principal Investigator: Pane Divisione di Medicina Interna-Ematologia, Ospedale San Luigi Gonzaga, Regione Gonzole 10 Recruiting Orbassano, Italy Contact: Giuseppe Saglio, Pr Principal Investigator: Saglio Azienda Ospedaliera di Padova Recruiting Padova, Italy, 35128 Contact: Gianpietro C. Semenzato, MD 39-049-821-2298 g.semenzato@unipd.it Ospedale Cervello Recruiting Palermo, Italy, 90146 Contact: Turri Azienda Ospedaliera Universitaria - Policlinico Paolo Giaccone Recruiting Palermo, Italy Contact: Clementina Caracciolo, Dr. Principal Investigator: Clementina Caracciolo, Dr. Principal Investigator: Rosaria Di Maggio, Dr. Dipartimento Oncologico - Ospedale S.Maria delle Croci Recruiting Ravenna, Italy Contact: Maria Salvucci, Dr. Principal Investigator: Maria Salvuci, Dr. Ospedale Recruiting Reggio Calabria, Italy Contact: Martino Principal Investigator: Martino Ospedale Recruiting Rimini, Italy Contact: Tosi Principal Investigator: Tosi U.O. di Ematologia - Centro Oncologico Basilicata Recruiting Rionero in Vulture, Italy Contact: Pellegrino Musto p.musto@tin.it Ematologia - Sapienza Università di Roma Recruiting Roma, Italy Principal Investigator: Giuliana Alimena, MD Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Recruiting Rome, Italy, 00168 Contact: Sica Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza Recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavila, Pr. n.cascavilla@operapadrepio.it Principal Investigator: Nicola Cascavilla, Pr. Principal Investigator: Lorella Melillo, Dr. U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Recruiting Siena, Italy, 53100 Contact: Monica BOCCHIA, Dr. Principal Investigator: Monica BOCCHIA, Dr. Ospedale Recruiting Taranto, Italy Contact: Iannitto Principal Investigator: Iannito SCDO Ematologia 2 AOU S. Giovanni Battista Recruiting Torino, Italy Contact: Patrizia Pregno, Dr. Principal Investigator: Patrizia Pregno, Dr. Sub-Investigator: Paola Riccomagno, Dr. Policlinico Universitario - Clinica Ematologia Recruiting Udine, Italy, 33100 Contact: Mario Tiribelli, Dr. Principal Investigator: Mario Tiribelli, Dr. Policlinico G. B. Rossi - Borgo Roma Recruiting Verona, Italy, 37134 Contact: Giovanni Pizzolo, MD giovanni.pizzolo@univr.it Principal Investigator: Giovanni PIZZOLO, Pr. Sub-Investigator: Dino DE VENERI, Dr. Collapse << |
NCT02693535 | Lymphoma, Non-Hodgkin ... more >> Multiple Myeloma Advanced Solid Tumors Collapse << | Phase 2 | Recruiting | - | - |
NCT02788201 | Urothelial Carcinoma ... more >> Bladder Cancer Urinary Bladder Neoplasms Collapse << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse << |
NCT01098500 | - | - | Completed | - | - |
NCT03515200 | Acute Lymphoblastic Leukemia, ... more >>in Relapse Acute Lymphoblastic Leukemia With Failed Remission Collapse << | Phase 1 | Recruiting | September 2022 | United States, Tennessee ... more >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD 866-278-5833 referralinfo@stjude.org Principal Investigator: Tanja A. Gruber, MD, PhD Collapse << |
NCT02465060 | Advanced Malignant Solid Neopl... more >>asm Bladder Carcinoma Breast Carcinoma Cervical Carcinoma Colon Carcinoma Colorectal Carcinoma Endometrial Carcinoma Esophageal Carcinoma Gastric Carcinoma Glioma Head and Neck Carcinoma Kidney Carcinoma Liver and Intrahepatic Bile Duct Carcinoma Lung Carcinoma Lymphoma Malignant Uterine Neoplasm Melanoma Ovarian Carcinoma Pancreatic Carcinoma Plasma Cell Myeloma Prostate Carcinoma Rectal Carcinoma Recurrent Bladder Carcinoma Recurrent Breast Carcinoma Recurrent Cervical Carcinoma Recurrent Colon Carcinoma Recurrent Colorectal Carcinoma Recurrent Esophageal Carcinoma Recurrent Gastric Carcinoma Recurrent Glioma Recurrent Head and Neck Carcinoma Recurrent Liver Carcinoma Recurrent Lung Carcinoma Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Melanoma Recurrent Ovarian Carcinoma Recurrent Pancreatic Carcinoma Recurrent Plasma Cell Myeloma Recurrent Prostate Carcinoma Recurrent Rectal Carcinoma Recurrent Skin Carcinoma Recurrent Thyroid Gland Carcinoma Recurrent Uterine Corpus Carcinoma Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Plasma Cell Myeloma Skin Carcinoma Thyroid Gland Carcinoma Uterine Corpus Cancer Collapse << | Phase 2 | Recruiting | - | - |
NCT01098500 | - | - | Completed | - | - |
NCT03746054 | Chronic Myeloid Leukemia (CML) | Phase 3 | Not yet recruiting | March 2023 | - |
NCT02428543 | Acute Myeloid Lukemia | Phase 1 Phase 2 | Recruiting | September 2020 | France ... more >> Dr Abdelaziz CHAIB Recruiting Aix-en-Provence, France, 13600 Contact: Abdelaziz CHAIB achaib@ch-aix.fr Principal Investigator: Abdelaziz CHAIB Chu Amiens Recruiting Amiens, France, 80054 Contact: MAROLLEAU Jean Pierre Principal Investigator: MAROLLEAU Jean Pierre CHU d'Angers Recruiting Angers, France, 49033 Contact: Martine GARDEMBAS Magardembas@chu-angers.fr Principal Investigator: Martine GARDEMBAS Hôpital VICTOR DUPOUY Recruiting Argenteuil, France, 95107 Contact: AL JIJAKLI Ahmad ahmad.aljijakli@ch-argenteuil.fr Principal Investigator: AL JIJAKLI Ahmad Dr Edouard RANDIAMALALA Recruiting Bayonne, France, 64100 Contact: Edouard RANDIAMALALA erandiamalala@ch-cotebasque.fr Principal Investigator: Edouard RANDIAMALALA CHU de Besançon Recruiting Besançon, France, 25030 Contact: Fabrice LAROSA flarosa@chu-besançon.fr Principal Investigator: Fabrice LAROSA Dr Thorsten BRAUN Recruiting Bobigny, France, 93000 Contact: Thorsten BRAUN thorsten.braun@aphp.fr Principal Investigator: Thorsten BRAUN CHU Boulogne Sur Mer Recruiting Boulogne Sur Mer cedex, France, 62321 Contact: CHOUFI Bachra b.choufi@ch-boulogne.fr Principal Investigator: CHOUFI Bachra Chr Clemenceau Recruiting Caen Cedex, France, 14033 Contact: REMAN Oumédaly reman-o@chu-caen.fr Principal Investigator: REMAN Oumédaly Hôpital d'Instruction des Armées PERCY Recruiting Clamart, France, 92141 Contact: Jean Valère MALFUSSON jvmalf@free.fr Principal Investigator: Jean Valère MALFUSSON Dr Stéphanie HAÏAT Recruiting Corbeil-essonnes, France, 91100 Contact: Stéphanie HAÏAT Principal Investigator: Stéphanie HAÏAT Hôpital Henri Mondor Recruiting Créteil, France, 94010 Contact: PAUTAS Cécile cecile.pautas@hmn.aphp.fr Principal Investigator: PAUTAS Cécile CHU de Dijon Not yet recruiting Dijon, France, 21079 Contact: CAILLOT Denis denis.caillot@chu-dijon.fr Principal Investigator: CAILLOT Denis Centre hospitalier de Versailles Recruiting Le Chesnay cedex, France, 78157 Contact: Rousselot Philippe 003339638622 phrousselot@ch-versailles.fr Principal Investigator: Rousselot Philippe Hôpital Claude Huriez Recruiting Lille cedex, France, 59037 Contact: QUESNEL Bruno bquesnel@chru-lille.fr Principal Investigator: QUESNEL Bruno CHRU Dupuytren Not yet recruiting Limoges cedex, France, 87042 Contact: TURLURE Pascal pascal.turlure@chu-limoges.fr Principal Investigator: TURLURE Pascal Hôpital Edouard Herriot Recruiting Lyon cedex 03, France, 69437 Contact: THOMAS Xavier xavier.thomas@chu-lyon.fr Principal Investigator: THOMAS Xavier Dr Regis COSTELLO Recruiting Marseille, France, 13000 Contact: Regis COSTELLO regis.costello@ap-hm.fr Principal Investigator: Regis COSTELLO Centre Hospitalier de Meaux Recruiting Meaux, France, 77104 Contact: FRAYFER Jamilé j-frayfer@ch-meaux.fr Principal Investigator: FRAYFER Jamilé Dr Mario OJEDA-URIBE Recruiting Mulhouse, France, 68000 Contact: Mario OJEDA-URIBE ojedam@ch-mulhouse.fr Principal Investigator: Mario OJEDA-URIBE Dr Jacques DELAUNAY Recruiting Nantes, France, 44000 Contact: Jacques DELAUNAY jacques.delaunay@chu-nantes.fr Principal Investigator: Jacques DELAUNAY CHU Nice, Hôpital Archet 1 Recruiting Nice cedex 3, France, 06202 Contact: MANNONE Lionel mannone.l@chu-nice.fr Principal Investigator: MANNONE Lionel CHU de Nîmes Recruiting Nîmes, France, 30029 Contact: Eric JOURDAN eric.jourdan@chu-nimes.fr Principal Investigator: Eric Jourdan Hôpital Saint Antoine Recruiting Paris cedex 12, France, 75751 Contact: ISNARD Françoise francoise.isnard@sat.aphp.fr Principal Investigator: ISNARD Françoise Hôpital Necker Enfants Malades Recruiting Paris cedex 15, France, 75743 Contact: SUAREZ Felipe felipe.suarez@nck.aphp.fr Principal Investigator: SUAREZ Felipe Hôpital Saint Louis Recruiting Paris, France, 75010 Contact: RAFFOUX Emmanuel emmanuel.raffoux@sls.ap-hop-paris.fr Principal Investigator: RAFFOUX Emmanuel Hôpital La Pitié Salpêtrière Recruiting Paris, France, 75013 Contact: UZUNOV Madalina madalina.uzunov@psl.aphp.fr Principal Investigator: UZUNOV Madalina Dr Laurence SANHES Suspended Perpignan, France, 66000 Dr Arnaud PIGNEUX Recruiting Pessac, France, 33604 Contact: Arnaud PIGNEUX arnaud.pigneux@chu-bordeaux.fr Principal Investigator: Arnaud PIGNEUX Centre Hospitalier René Dubos Recruiting Pontoise Cedex, France, 95303 Contact: VAIDA Iona Dana ioana.vaida@ch-pontoise.fr Principal Investigator: VAIDA Iona Dana Marc BERNARD Recruiting Rennes, France, 35000 Contact: Marc BERNARD marc.bernard@chu-rennes.fr Principal Investigator: Marc BERNARD Dr Emilie LEMASLE Recruiting Rouen, France, 76000 Contact: Emilie LEMASLE emilie.lemasle@chb.unicancer.fr Principal Investigator: Emilie LEMASLE Centre Hospitalier René Huguenin Suspended Saint Cloud, France, 92210 Institut de Cancérologie de la Loire Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Emmanuelle TAVERNIER-TARDY emmanuelle.tavernier@icloire.fr Principal Investigator: Emmanuelle TAVERNIER-TARDY Dr Réda GARIDI Recruiting Saint-Quentin, France, 02100 Contact: Réda GARIDI Principal Investigator: Réda GARIDI Dr Christian RECHER Recruiting Toulouse, France, 31000 Contact: Christian RECHER Principal Investigator: Christian RECHER Centre Hospitalier de Valenciennes Recruiting Valenciennes, France, 59322 Contact: FERNANDES José fernandes-j@ch-valenciennes.fr Principal Investigator: FERNANDES José Collapse << |
NCT02883036 | - | - | Not yet recruiting | - | China, Guangdong ... more >> Department of hematology,Nanfang Hospital Not yet recruiting Guangzhou, Guangdong, China, 510515 Contact: Xiaoli Liu, MD 86-020-61641616 lxl2405@126.com Contact: Na Xu, MD 86-020-61641615 292347668@qq.com Collapse << |
NCT01901666 | Chronic Myelogenous Leukemia ... more >> Short Stature Collapse << | Phase 4 | Unknown | December 2014 | India ... more >> Postgraduate Institute of Medical Education and Research Recruiting Chandigarh, UT, India, 160012 Contact: anil bhansali, MBBS,MD,DM 9316977995 anilbhansaliendocrine@rediffmail.com Collapse << |
NCT01215487 | - | - | Recruiting | October 2019 | Canada, British Columbia ... more >> Leukemia BMT program of BC, Vancouver General Hospital, Hematology Research and Clinical Trials Unit Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Collapse << |
靶点 | Description | IC50 |
---|---|---|
Abl | IC50:1nM | |
c-Kit | IC50:79nM | |
c-Kit (D816V) | IC50:37nM | |
Src | IC50:0.8nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网